As Filed with the Securities and Exchange Commission on May 13, 2009

 

Registration No. 333-                 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM S-8

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 


 

BRIDGEPOINT EDUCATION, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of

incorporation or organization)

 

59-3551629

(I.R.S. Employer

Identification No.)

 

 

 

13500 Evening Creek Drive North,
Suite 600

San Diego, California

 

92128

(Address of Principal Executive Offices)

 

(Zip Code)

 


 

Bridgepoint Education, Inc. Amended and Restated 2005 Stock Incentive Plan

Bridgepoint Education, Inc. 2009 Stock Incentive Plan (as amended and restated March 31, 2009)

Bridgepoint Education, Inc. Employee Stock Purchase Plan (as amended and restated March 31, 2009)

Stock Option Agreement between Bridgepoint Education, Inc. (“Bridgepoint”) and Hope Gardina, dated February 15, 2006

Stock Option Agreement between Bridgepoint and Larry Barker, dated February 15, 2006

Stock Option Agreement between Bridgepoint and Sean Gousha, dated February 15, 2006

Stock Option Agreement between Bridgepoint and Megan Williams, dated February 15, 2006

Stock Option Agreement between Bridgepoint and Adam Forrest, dated February 15, 2006

Stock Option Agreement between Bridgepoint and Dan Stoneman, dated February 15, 2006

Stock Option Agreement between Bridgepoint and Sheri Jones, dated February 15, 2006

Common Stock Purchase Warrant between TeleUniversity, Inc. (“TeleUniversity”) and Holly Boren, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and John Cacciatore, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Frederick Chaffee, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Bob Christie, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Linda M. Clugston, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and R. Wayne Clugston, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Frank Di Pietro, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Paul Elsner, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Billy Escue, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Oscar T. Lenning, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Ray Levesque, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Brady Merkel, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Larry Miller, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Mary Obrochta, dated November 12, 2003

Common Stock Purchase Warrant between Bridgepoint and Lisa Vande Pol, dated November 21, 2008

Common Stock Purchase Warrant between TeleUniversity and Kathy Randa, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Teresa Ronngren, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Bruce J. Stewart, dated November 12, 2003

Common Stock Purchase Warrant between TeleUniversity and Scott Turner, dated November 12, 2003

Common Stock Purchase Warrant between Bridgepoint and David Vande Pol, dated November 14, 2008

Common Stock Purchase Warrant between TeleUniversity and Lynn E. Weaver, dated November 12, 2003

(Full title of the plans)

 


 

Andrew S. Clark

CEO and President

Bridgepoint Education, Inc.

13500 Evening Creek Drive North, Suite 600

San Diego, California, 92128

 (Name and Address of Agent For Service)

 

(858) 668-2586

(Telephone number, including area code, of agent for service)

 

Copy to:

John J. Hentrich, Esq.

Jeralin R. Cardoso, Esq.

Sheppard, Mullin, Richter & Hampton LLP

12275 El Camino Real, Suite 200

San Diego, California  92130

 


 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

 Large Accelerated filer o

 

Accelerated filer o

 

Non-accelerated filer x
(Do not check if a smaller
reporting company)

 

Smaller reporting company o

 

CALCULATION OF REGISTRATION FEE

 

Title of  Securities to be Registered(1)

 

Amount to be
Registered (4)

 

Proposed
Maximum
Offering Price
Per Share

 

Proposed Maximum
Aggregate Offering
Price

 

Amount of 
Registration Fee

 

Common Stock, par value $0.01 per share: In respect of stock options (2)

 

8,659,056 shares

 

$

0.3756

(5)

$

3,251,912.04

(5)

$

181.46

 

Common Stock, par value $0.01 per share: To be issued under the Bridgepoint Education, Inc. 2009 Stock Incentive Plan

 

5,000,000 shares

 

$

10.3452

(6)

$

51,725,857.32

(6)

$

2,886.30

 

Common Stock, par value $0.01 per share: To be issued under the Bridgepoint Education, Inc. Employee Stock Purchase Plan

 

1,000,000 shares

 

$

9.646

(7)

$

9,645,825.00

(7)

$

538.24

 

Common Stock, par value $0.01 per share: subject to the outstanding options under the:

 

 

 

 

 

 

 

 

 

Option Agreement between Bridgepoint and Hope Gardina

 

29,806 shares

 

$

0.315

(8)

$

9,388.89

(8)

$

0.52

 

Option Agreement between Bridgepoint and Larry Barker

 

5,960 shares

 

$

0.315

(8)

$

1,877.40

(8)

$

0.10

 

Option Agreement between Bridgepoint and Sean Gousha

 

5,960 shares

 

$

0.315

(8)

$

1,877.40

(8)

$

0.10

 

Option Agreement between Bridgepoint and Megan Williams

 

5,960 shares

 

$

0.315

(8)

$

1,877.40

(8)

$

0.10

 

Option Agreement between Bridgepoint and Adam Forrest

 

5,960 shares

 

$

0.315

(8)

$

1,877.40

(8)

$

0.10

 

Option Agreement between Bridgepoint and Dan Stoneman

 

5,960 shares

 

$

0.315

(8)

$

1,877.40

(8)

$

0.10

 

Option Agreement between Bridgepoint and Sheri Jones

 

5,960 shares

 

$

0.315

(8)

$

1,877.40

(8)

$

0.10

 

Common Stock, par value $0.01 per share: subject to the outstanding warrants under the (3):

 

 

 

 

 

 

 

 

 

Warrant Agreement between TeleUniversity and Holly Boren

 

222 shares

 

$

1.125

(8)

$

249.75

(8)

$

0.01

 

Warrant Agreement between TeleUniversity and John Cacciatore

 

4,444 shares

 

$

1.125

(8)

$

4,999.50

(8)

$

0.28

 

Warrant Agreement between TeleUniversity and Frederick Chaffee

 

666 shares

 

$

1.125

(8)

$

749.25

(8)

$

0.04

 

Warrant Agreement between TeleUniversity and Bob Christie

 

2,222 shares

 

$

1.125

(8)

$

2,499.75

(8)

$

0.14

 

Warrant Agreement between TeleUniversity and Linda M. Clugston

 

19,555 shares

 

$

2.925

(8)

$

57,198.38

(8)

$

3.19

 

Warrant Agreement between TeleUniversity and R. Wayne Clugston

 

172,222 shares

 

$

2.835

(8)

$

488,249.37

(8)

$

27.24

 

Warrant Agreement between TeleUniversity and Frank Di Pietro

 

4,444 shares

 

$

1.125

(8)

$

4,999.50

(8)

$

0.28

 

Warrant Agreement between TeleUniversity and Paul Elsner

 

5,555 shares

 

$

1.125

(8)

$

6,249.38

(8)

$

0.35

 

Warrant Agreement between TeleUniversity and Billy Escue

 

11,111 shares

 

$

1.125

(8)

$

12,499.88

(8)

$

0.70

 

Warrant Agreement between TeleUniversity and Oscar T. Lenning

 

4,444 shares

 

$

1.125

(8)

$

4,999.50

(8)

$

0.28

 

Warrant Agreement between TeleUniversity and Ray Levesque

 

3,333 shares

 

$

1.125

(8)

$

3,749.63

(8)

$

0.21

 

Warrant Agreement between TeleUniversity and Brady Merkel

 

11,111 shares

 

$

1.125

(8)

$

12,499.88

(8)

$

0.70

 

Warrant Agreement between TeleUniversity and Larry Miller

 

2,222 shares

 

$

1.125

(8)

$

2,499.75

(8)

$

0.14

 

Warrant Agreement between TeleUniversity and Mary Obrochta

 

4,000 shares

 

$

2.25

(8)

$

9,000.00

(8)

$

0.50

 

Warrant Agreement between TeleUniversity and Kathy Randa

 

2,222 shares

 

$

1.125

(8)

$

2,499.75

(8)

$

0.14

 

Warrant Agreement between Bridgepoint and Lisa Vande Pol

 

5,555 shares

 

$

2.25

(8)

$

12,498.75

(8)

$

0.70

 

 

 

2,777 shares

 

$

9.00

(8)

$

24,993.00

(8)

$

1.39

 

 

 

41,111 shares

 

$

2.25

(8)

$

92,499.75

(8)

$

5.16

 

Warrant Agreement between TeleUniversity and Teresa Ronngren

 

4,444 shares

 

$

2.25

(8)

$

9,999.00

(8)

$

0.56

 

Warrant Agreement between TeleUniversity and Bruce J. Stewart

 

5,555 shares

 

$

1.125

(8)

$

6,249.38

(8)

$

0.35

 

Warrant Agreement between TeleUniversity and Scott Turner

 

33,333 shares

 

$

4.50

(8)

$

149,998.50

(8)

$

8.37

 

 

 

133,333 shares

 

$

4.50

(8)

$

599,998.50

(8)

$

33.48

 

 

 

38,889 shares

 

$

2.25

(8)

$

87,500.25

(8)

$

4.88

 

Warrant Agreement between Bridgepoint and David Vande Pol

 

5,555 shares

 

$

2.25

(8)

$

12,498.75

(8)

$

0.70

 

 

 

2,777 shares

 

$

9.00

(8)

$

24,993.00

(8)

$

1.39

 

 

 

26,389 shares

 

$

2.25

(8)

$

59,375.25

(8)

$

3.31

 

Warrant Agreement between TeleUniversity and Lynn E. Weaver

 

5,555 shares

 

$

1.125

(8)

$

6,249.38

(8)

$

0.35

 

TOTAL

 

15,277,668 shares

 

N/A

 

$

66,344,044.40

 

$

3,702.00

(9)

 

 

 



 

(1)

 

The securities to be registered include options, warrants and rights to acquire Common Stock.

 

 

 

(2)

 

Represents shares subject to issuance upon exercise of stock options outstanding under the Bridgepoint Education, Inc. Amended and Restated 2005 Stock Incentive Plan.

 

 

 

(3)

 

TeleUniversity, Inc. was the predecessor-in-interest to Bridgepoint Education Inc.

 

 

 

(4)

 

Pursuant to Rule 416, this Registration Statement shall also cover any additional shares of Common Stock which become issuable under the Bridgepoint Education, Inc. Amended and Restated 2005 Stock Incentive Plan, Bridgepoint Education, Inc. 2009 Stock Incentive Plan (as amended and restated March 31, 2009) , Bridgepoint Education, Inc. Employee Stock Purchase Plan (as amended and restated March 31, 2009), Bridgepoint Education, Inc. Options and Bridgepoint Education, Inc. Warrants by reason of any stock split, stock dividend, recapitalization or any other similar transaction effected without receipt of consideration, which results in an increase in the Registrant’s outstanding shares of Common Stock.

 

 

 

(5)

 

Estimated pursuant to Rule 457(h) under the Securities Act of 1933, as amended, solely for the purpose of calculating the registration fee, on the basis of the weighted average exercise price of the outstanding stock options.

 

 

 

(6)

 

(i)  Estimated pursuant to Rule 457(h) under the Securities Act of 1933, as amended, solely for the purpose of calculating the registration fee, on the basis of the exercise price of each outstanding stock option.

 

(ii) Estimated pursuant to Rules 457(c) and 457(h) under the Securities Act of 1933, as amended, solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the Common Stock as reported on the New York Stock Exchange on May 11, 2009 , as set forth in the following table:

 

Type of Shares

 

Number of Shares

 

Exercise Price Per
Share ($)

 

Maximum Aggregate
Offering Price ($)

 

Shares subject to currently outstanding stock options issued under the Bridgepoint Education, Inc. 2009 Stock Incentive Plan (i)

 

2,765,822

 

10.50

 

29,041,131.00

 

Shares reserved for future issuance under the Bridgepoint Education, Inc. 2009 Stock Incentive Plan (ii)

 

2,234,178

 

10.154

 

22,684,726.32

 

TOTAL:

 

5,000,000

 

 

 

 

 

 

(7)

 

Estimated pursuant to Rules 457(c) and 457(h) under the Securities Act of 1933, as amended, solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the Common Stock as reported on the New York Stock Exchange on May 11, 2009, multiplied by 95%, which is the current percentage of the trading purchase price applicable to purchases under the referenced Plan.

 

 

 

(8)

 

Estimated pursuant to Rule 457(h) under the Securities Act of 1933, as amended, solely for the purpose of calculating the registration fee, on the basis of the respective exercise prices of the outstanding respective options or warrants.

 

 

 

(9)

 

$969 of the registration fee for this registration statement is being offset, pursuant to Rule 457(p) under the Securities Act of 1933, as amended, by the registration fee paid in connection with unsold securities registered by the registrant under Registration Statement No. 333-156408 (initially filed on December 22, 2008).

 

The Registration Statement shall become effective upon filing in accordance with Rule 462(a) under the Securities Act of 1933.

 



 

PART I

 

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

 

Item 1. Plan Information.*

 

Item 2. Registrant Information and Employee Program Annual Information.*

 

* Information required by Part I to be contained in the Section 10(a) prospectus is omitted from this Registration Statement in accordance with Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”) and the Note to Part I of Form S-8.

 

PART II

 

INFORMATION REQUIRED IN REGISTRATION STATEMENT

 

Item 3.  Incorporation of Documents by Reference.

 

The following documents filed by the Registrant with the Securities and Exchange Commission (“SEC”) are hereby incorporated by reference into this Registration Statement:

 

(a)

The Registrant’s prospectus filed with the SEC pursuant to Rule 424(b) promulgated under the Securities Act filed on April 16, 2009, in connection with the Registrant’s Registration Statement on Form S-1 (Registration No. 333-156408), as amended, in which there is set forth the audited consolidated financial statements for the Registrant’s fiscal year ended December 31, 2008;

 

 

(b)

All reports filed by the Registrant pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the Registrant’s latest annual report; and

 

 

(c)

The description of the Registrant’s common stock contained in the Registrant’s Registration Statement on Form 8-A (File No. 001-34272) filed with the SEC on March 30, 2009, pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including any amendments or reports filed for the purpose of updating such descriptions.

 

In addition, all documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, after the date of this registration statement and prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, will be incorporated by reference into this registration statement from the date of filing of such documents.

 

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purposes of this registration statement to the extent that a statement contained herein or in any other subsequently filed document which also is or deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.

 

Item 4. Description of Securities.

 

Not applicable.

 

Item 5.  Interests of Named Experts and Counsel.

 

Not applicable.

 



 

Item 6.  Indemnification of Directors and Officers.

 

Section 145 of the Delaware General Corporation Law (the “DGCL”) provides that a corporation may indemnify directors and officers as well as other employees and individuals against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with any threatened, pending or completed actions, suits or proceedings in which such person is made a party by reason of such person being or having been a director, officer, employee or agent of the corporation. Section 145 of the DGCL also provides that expenses (including attorneys’ fees) incurred by a director or officer in defending an action may be paid by a corporation in advance of the final disposition of an action if the director or officer undertakes to repay the advanced amounts if it is determined such person is not entitled to be indemnified by the corporation.  In addition, the DGCL provides, in general, that a corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation against any liability asserted against such person and incurred by such person in any such capacity, or arising out of his or her status as such, whether or not the corporation would have the power to indemnify the person against such liability under Section 145 of the DCGL.  The DGCL provides that Section 145 is not exclusive of other rights to which those seeking indemnification may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise.

 

Section 102(b)(7) of the DGCL permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (i) for any breach of the director’s duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) for unlawful payments of dividends or unlawful stock repurchases, redemptions or other distributions, or (iv) for any transaction from which the director derived an improper personal benefit.

 

Article 7 of the Registrant’s Fifth Amended and Restated Certificate of Incorporation (Exhibit 3.3 of the Registrant’s Registration Statement on Form S-1 (Registration No. 333-156408), as amended “Registrant’s Form S-1”)) limits the liability of the Registrant’s directors and officers and provides that such directors and officers will not be personally liable for monetary damages for breach of their fiduciary duties as directors or officers, except liability: (i) for any breach of a director’s or officer’s duty of loyalty to the Registrant or its stockholders, (ii) for intentional misconduct, fraud or a knowing violation of the law, (iii) under Section 174 of the DGCL, or (iv) for any transaction from which a director or officer derives an improper personal benefit. The Fifth Amended and Restated Certificate of Incorporation also provides that the Registrant shall indemnify and hold harmless its directors and officers to the fullest extent authorized under the laws of the State of Delaware.  In addition, the Fifth Amended and Restated Certificate of Incorporation provides that the Registrant’s Board of Directors shall have the power to indemnify Registrant’s employees and agents.

 

Article VIII of the Registrant’s Second Amended and Restated Bylaws (Exhibit 3.4 to the Registrant’s Form S-1) provides that the Registrant shall indemnify its directors, officers, employees and agents made a party to any proceeding, by reason of the fact that he/she is or was a director or officer or employee or agent of the Registrant.  Indemnification is only available in instances in which the defendant acted in good faith for a purpose which he/she reasonably believed to be in Registrant’s best interest.  In criminal proceedings, the defendant additionally must have had no reasonable cause to believe that his/her conduct was unlawful.

 

Additionally, as permitted by Delaware law, the Registrant has entered into indemnification agreements with each of its directors and officers that require the Registrant to indemnify such persons, to the fullest extent authorized or permitted under Delaware law, against any and all costs and expenses (including attorneys’, witness or other professional fees) actually and reasonably incurred by such persons in connection with the investigation, defense, settlement or appeal of any action, hearing, suit or other proceeding, whether pending, threatened or completed, to which any such person may be made a witness or a party by reason of (1) the fact that such person is or was a director, officer, employee or agent of the registrant or its subsidiaries, whether serving in such capacity or otherwise acting at the request of the registrant or its subsidiaries and (2) anything done or not done, or alleged to have been done or not done, by such person in that capacity.  The indemnification agreements also require the Registrant to advance expenses incurred by directors and officers within 20 days after receipt of a written request, provided that such persons undertake to repay such amounts if it is ultimately determined that they are not entitled to

 



 

indemnification.  Additionally, the agreements set forth certain procedures that will apply in the event of a claim for indemnification thereunder, including a presumption that directors and officers are entitled to indemnification under the agreements, and that the Registrant has the burden of proof to overcome that presumption in reaching any contrary determination.  The Registrant is not required to provide indemnification under the agreements for certain matters, including: (1) indemnification beyond that permitted by Delaware law; (2) indemnification for liabilities for which the officer or director is reimbursed pursuant to such insurance as may exist for such person’s benefit; (3) indemnification related to disgorgement of profits under Section 16(b) of the Securities Exchange Act of 1934; (4) in connection with certain proceedings initiated against the Registrant by the director or officer; or (5) indemnification for settlements the director or officer enters into without the Registrant’s written consent.  The indemnification agreements require the Registrant to maintain directors’ and officers’ insurance in full force and effect while any director or officer continues to serve in such capacity, and so long as any such person may incur costs and expenses related to legal proceedings as described above.

 

Item 7.

Exemption From Registration Claimed.

 

 

 

Not applicable.

 

 

Item 8.

Exhibits.

 

Exhibit No.

 

Description of Document

 

 

 

4.1

 

Fifth Amended and Restated Certificate of Incorporation of Bridgepoint Education, Inc. (incorporated herein by reference to Exhibit 3.3 to the Registrant’s Form S-1).

 

 

 

4.2

 

Second Amended and Restated Bylaws of Bridgepoint Education, Inc. (incorporated herein by reference to Exhibit 3.4 to the Registrant’s Form S-1).

 

 

 

5.1

 

Opinion of Sheppard, Mullin, Richter & Hampton LLP.

 

 

 

5.2

 

Opinion of Richards, Layton & Finger P.A.

 

 

 

23.1

 

Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm.

 

 

 

23.2

 

Consent of Sheppard, Mullin, Richter & Hampton LLP (included in Exhibit 5.1).

 

 

 

23.3

 

Consent of Richards, Layton & Finger P.A. (included in Exhibit 5.2).

 

 

 

24.1

 

Power of Attorney.

 

 

 

99.1

 

Bridgepoint Education, Inc. Amended and Restated 2005 Stock Incentive Plan (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Form S-1).

 

 

 

99.2

 

Bridgepoint Education, Inc. 2009 Stock Incentive Plan (as amended and restated March 31, 2009) (incorporated herein by reference to Exhibit 10.5 to the Registrant’s Form S-1).

 

 

 

99.3

 

Bridgepoint Education, Inc. Employee Stock Purchase Plan (as amended and restated March 31, 2009) (incorporated herein by reference to Exhibit 10.6 to the Registrant’s Form S-1).

 

 

 

99.4

 

Form of Nonstatutory Stock Option Agreement for Executives and Senior Management for the 2009 Stock Incentive Plan.

 

 

 

99.5

 

Form of Incentive Stock Option Agreement for Executives and Senior Management for the 2009 Stock Incentive Plan.

 

 

 

99.6

 

Form of Stock Option Agreement for Options Issued outside of plan.

 

 

 

99.7

 

Form of Warrant Agreement for Warrants Issued outside of plan (incorporated herein by reference to Exhibit 4.10 to the Registrant’s Form S-1).

 



 

Item 9. Undertakings.

 

 

(a)

The undersigned Registrant hereby undertakes:

 

 

 

 

 

(1)           To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

 

 

 

 

 

 

(i)      to include any prospectus required by Section 10(a)(3) of the Securities Act;

 

 

 

 

 

 

 

(ii)     to reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement;

 

 

 

 

 

 

 

(iii)     to include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

 

 

 

 

 

 

 

Provided, however , that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

 

 

 

 

 

(2)           That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

 

 

 

 

(3)           To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

 

 

(b)           The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

 

 

(c)           Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 



 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on May 13, 2009.

 

 

BRIDGEPOINT EDUCATION, INC.

 

 

 

By:

/s/ Andrew S. Clark

 

 

Andrew S. Clark

 

 

CEO and President

 



 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

 

Name and Signature

 

Title

 

Date

 

 

 

 

 

/s/ ANDREW S. CLARK

 

CEO (Principal Executive Officer) and

 

 

Andrew S. Clark

 

President and a Director

 

May 13, 2009

 

 

 

 

 

/s/ DANIEL J. DEVINE

 

Chief Financial Officer (Principal Financial

 

 

Daniel J. Devine

 

Officer and Principal Accounting Officer)

 

May 13, 2009

 

Directors:

 

Ryan Craig

Dale Crandall

Patrick T. Hackett

Robert Hartman

Adarsh Sarma

 

By:

 

/s/ ANDREW S. CLARK

 

 

 

May 13, 2009

 

 

 

 

 

Andrew S. Clark

 

 

 

 

Attorney-in-Fact

 

 

 

 

 



 

INDEX TO EXHIBITS

 

The following documents are filed as exhibits to this registration statement:

 

Exhibit No.

 

Description of Document

4.1

 

Fifth Amended and Restated Certificate of Incorporation of Bridgepoint Education, Inc. (incorporated herein by reference to Exhibit 3.3 to the Registrant’s Form S-1).

 

 

 

4.2

 

Second Amended and Restated Bylaws of Bridgepoint Education, Inc. (incorporated herein by reference to Exhibit 3.4 to the Registrant’s Form S-1).

 

 

 

5.1

 

Opinion of Sheppard, Mullin, Richter & Hampton LLP.

 

 

 

5.2

 

Opinion of Richards, Layton & Finger P.A.

 

 

 

23.1

 

Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm.

 

 

 

23.2

 

Consent of Sheppard, Mullin, Richter & Hampton LLP (included in Exhibit 5.1).

 

 

 

23.3

 

Consent of Richards, Layton & Finger P.A. (included in Exhibit 5.2).

 

 

 

24.1

 

Power of Attorney.

 

 

 

99.1

 

Bridgepoint Education, Inc. Amended and Restated 2005 Stock Incentive Plan (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Form S-1).

 

 

 

99.2

 

Bridgepoint Education, Inc. 2009 Stock Incentive Plan (as amended and restated March 31, 2009) (incorporated herein by reference to Exhibit 10.5 to the Registrant’s Form S-1).

 

 

 

99.3

 

Bridgepoint Education, Inc. Employee Stock Purchase Plan (as amended and restated March 31, 2009) (incorporated herein by reference to Exhibit 10.6 to the Registrant’s Form S-1).

 

 

 

99.4

 

Form of Nonstatutory Stock Option Agreement for Executives and Senior Management for the 2009 Stock Incentive Plan.

 

 

 

99.5

 

Form of Incentive Stock Option Agreement for Executives and Senior Management for the 2009 Stock Incentive Plan.

 

 

 

99.6

 

Form of Stock Option Agreement for Options Issued outside of plan.

 

 

 

99.7

 

Form of Warrant Agreement for Warrants Issued outside of plan (incorporated herein by reference to Exhibit 4.10 to the Registrant’s Form S-1).

 


EXHIBIT 5.1

 

OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP

 

May 13, 2009

 

Bridgepoint Education, Inc.

13500 Evening Creek Drive North

Suite 600

San Diego, California  92128

 

 

Re:                                Registration Statement on Form S-8

 

Ladies and Gentlemen:

 

We have acted as special counsel to Bridgepoint Education, Inc., a Delaware corporation (the “Company”), in connection with the filing of a registration statement on Form S-8 (the “Registration Statement”) under the Securities Act of 1933, as amended, covering 15,277,668 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), which may be issued pursuant to the Company’s Amended and Restated 2005 Stock Incentive Plan (the “2005 Plan”), the Company’s 2009 Stock Incentive Plan, amended and restated as of March 31, 2009 (the “2009 Plan”), the Company’s Employee Stock Purchase Plan, amended and restated as of March 31, 2009 (the “ESPP”) (collectively, the 2005 Plan, 2009 Plan and ESPP hereinafter will be referred to as the “Plans”), stock options outside of the Plans (the “Options”), or warrants outside of the Plans (the “Warrants”), comprised of:

 

a) up to 8,659,056 shares of Common Stock that may be issued pursuant to outstanding stock options under the 2005 Plan;

 

b) up to 5,000,000 shares of Common Stock that may be issued pursuant to awards granted under the 2009 Plan;

 

c) up to 1,000,000 shares of Common Stock reserved for issuance under the ESPP;

 

d) up to 65,566 shares of Common Stock that may be issued pursuant to the Options; and

 

e) up to 553,046 shares of Common Stock that may be issued pursuant to the Warrants.

 

This opinion is being furnished in accordance with the requirements of Item 8 of Form S-8 and Item 601(b)(5)(i) of Regulation S-K.

 

In connection with this opinion, we have reviewed the Registration Statement, the Company’s charter documents, the proceedings taken by the Company with respect to the authorization and adoption of the 2005 Plan, 2009 Plan, the ESPP, the Options and the Warrants, certificates of government officials, and such other documents, records, certificates, memoranda and other instruments as we deem necessary as a basis for this opinion. With respect to the foregoing documents, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the conformity to originals of all documents submitted to us as certified or reproduced copies.  We have also assumed that either (i) the stock certificates to be issued to represent the Shares (collectively, the “Stock Certificates”) will conform to the specimen common stock certificate submitted to us, and such Stock Certificates will be duly executed by the Company and countersigned by the transfer agent therefor in accordance with Section 158 of the Delaware General Corporation Law (“Section 158”), or (ii) the Shares will be uncertificated in accordance with Section 158 and the Company’s Bylaws, and the transfer agent therefor will register the purchaser thereof as the registered owner of any uncertificated Shares on its stock transfer books and

 



 

records.  We have further assumed that (a) shares currently reserved will remain available for the issuance of the Shares, and (b) neither the Company’s charter documents nor any of the proceedings relating to either the Plans or to the Options or to the Warrants, or any of the option agreements relating to the Shares, will be rescinded, amended or otherwise modified prior to the issuance of the Shares.  We have obtained from the officers of the Company certificates as to certain factual matters and, insofar as this opinion is based on matters of fact, we have relied on such certificates without independent investigation.

 

In rendering the opinion set forth below, we have relied on the opinion to you of Richards, Layton & Finger, P.A., dated as of the date hereof with respect to certain matters governed by Delaware law.

 

Based on the foregoing review, and in reliance thereon, we are of the opinion that if, as and when the Shares are issued and sold by the Company in accordance with the terms of the stock option or other agreements provided for under the applicable Plan or the Options or the Warrants, as applicable, and payment in full of the consideration therefor is received by the Company, the Shares will be validly issued, fully paid and nonassessable.

 

We consent to the filing of this opinion letter as Exhibit 5.1 to the Registration Statement.  In giving this consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, the rules and regulations of the Securities and Exchange Commission promulgated thereunder or Item 509 of Regulation
S-K.

 

We express no opinion as to matters governed by any laws other than the Delaware General Corporation Law, the applicable provisions of the Delaware Constitution and reported decisions of the Delaware courts interpreting these respective laws.

 

Our opinion is expressly limited to the matters set forth above, and we render no opinion, whether by implication or otherwise, as to any other matters relating to the Company, the Shares, the Plans, the Options, the Warrants, the option or other agreements related to the Shares, or the Registration Statement.

 

 

Respectfully submitted,

 

 

 

By: /s/ SHEPPARD, MULLIN, RICHTER & HAMPTON LLP

 

 

 

 Sheppard, Mullin, Richter and Hampton LLP

 


Exhibit 5.2

 

[RICHARDS LAYTON & FINGER LETTERHEAD]

 

May 13, 2009

 

Bridgepoint Education, Inc.

13500 Evening Creek Drive North, Suite 600

San Diego, California 92128

 

Re:                                Registration Statement on Form S-8

 

Ladies and Gentlemen:

 

We have acted as special Delaware counsel to Bridgepoint Education, Inc., a Delaware corporation (the “Company”), in connection with the matters set forth herein.  You have requested our opinion with respect to certain matters in connection with the filing by the Company of a Registration Statement on Form S-8 (the “Registration Statement”) under the Securities Act of 1933, as amended, covering 15,277,668 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), which may be issued pursuant to the Company’s Amended and Restated 2005 Stock Incentive Plan (the “2005 Plan”), the Company’s 2009 Stock Incentive Plan, as amended and restated as of March 31, 2009 (the “2009 Plan”), the Company’s Employee Stock Purchase Plan (the “ESPP” and, collectively with the 2005 Plan and the 2009 Plan, the “Plans”), stock options outside of the Plans (the “Options”) or warrants outside of the Plans (the “Warrants”) comprised of (a) up to 8,659,056 shares of Common Stock that may be issued pursuant to outstanding stock options under the 2005 Plan, (b) up to 5,000,000 shares of Common Stock that may be issued pursuant to awards granted under the 2009 Plan, (c) up to 1,000,000 shares of Common Stock reserved for issuance under the ESPP, (d) up to 65,566 shares of Common Stock that may be issued pursuant to the Options, and (e) up to 553,046 shares of Common Stock that may be issued pursuant to the Warrants.

 

For the purpose of rendering our opinion as expressed herein, we have been furnished and have reviewed copies of the following documents:

 

(i)                                      the Certificate of Incorporation of the Company as filed with the Secretary of State of the State of Delaware (the “Secretary of State”) on May 21, 1999, as amended by the Certificate of Merger as filed with the Secretary of State on January 24, 2001, the Certificate of Amendment as filed with the Secretary of State on January 24, 2001, the Amended and Restated

 



 

Certificate of Incorporation as filed with the Secretary of State on November 25, 2003, the Second Amended and Restated Certificate of Incorporation as filed with the Secretary of State on March 30, 2005, the Third Amended and Restated Certificate of Incorporation as filed with the Secretary of State on July 27, 2005, the Fourth Amended and Restated Certificate of Incorporation as filed with the Secretary of State on July 29, 2005, the Certificates of Correction as filed with the Secretary of State on December 11, 2008 and January 9, 2009, and the Certificate of Amendment as filed with the Secretary of State on March 31, 2009 (collectively, the “Certificate of Incorporation”);

 

(ii)                                   the Bylaws of the Company, the Amended and Restated Bylaws of the Company, and the amendments thereto (the “Bylaws”);

 

(iii)                                the records of the Company, including the records of the proceedings of the Board of Directors of the Company (the “Board”) and the stockholders of the Company;

 

(iv)                               the memorandum, dated March 31, 2009, prepared by Sheppard Mullin Richter & Hampton LLP (“Sheppard Mullin”) summarizing the results of its due diligence review with respect to the outstanding shares of the capital stock of the Company; and

 

(v)                                  the legal opinion of Sheppard Mullin, counsel to the Company, dated April     , 2009, addressed to you, as to the matters set forth therein.

 

With respect to the foregoing documents, we have assumed:  (a) the genuineness of all signatures, and the incumbency, authority, legal right and power and legal capacity under all applicable laws and regulations, of the officers and other persons and entities signing each of the said documents as or on behalf of the parties thereto; (b) the authenticity of all documents submitted to us as originals; (c) the conformity to authentic originals of all documents submitted to us as certified, conformed, photostatic or other copies; and (d) that the foregoing documents, in the forms submitted to us for our review, have not been and will not be altered or amended in any respect material to our opinion as expressed herein.  For the purpose of rendering our opinion as expressed herein, we have not reviewed any documents other than the documents listed above, and we assume there exists no provision of any such other document that bears upon or is inconsistent with our opinion as expressed herein.  We have conducted no independent factual investigation of our own, but rather have relied solely upon the foregoing documents, the statements and information set forth therein, and the additional matters recited or assumed herein, all of which we assume to be true, complete and accurate in all material respects.

 

Background

 

The Company was organized as a Delaware corporation on May 21, 1999, through the filing by its incorporator of its original Certificate of Incorporation with the Secretary of State.  Under its original Certificate of Incorporation, the Company was authorized to issue up to 2,000 shares of Common Stock.  No director was named in the original Certificate of Incorporation; rather, the incorporator, acting by written consent, appointed Michael Clifford as the sole initial director.  That consent, however, was lost, and neither the Company nor the

 

2



 

incorporator has been able to locate it, despite diligent efforts to do so.  On November 20, 2003, Mr. Clifford executed an affidavit confirming that the incorporator had elected him as the sole initial director on May 21, 1999.

 

On May 21, 1999, Mr. Clifford, acting by written consent as sole director, adopted the Company’s organizational resolutions and authorized the issuance of 500 shares of Common Stock to each of Mr. Clifford and Louis Falcigno, in recognition of past services they provided to the Company in their capacities as founders.  Pursuant to such resolutions, the Board ratified the filing of the Certificate of Incorporation, adopted the initial Bylaws, appointed the Company’s officers and fixed the number of directors at two (but did not fill the vacancy created by the expansion).

 

On June 7, 1999, Messrs. Clifford and Falcigno, constituting all of the members of the Board, executed a written consent authorizing the offer of shares of Common Stock in units, each unit consisting of 100,000 shares, with a minimum of 20 units and a maximum of 30 units to be sold in the offering.  In connection with this offering, the Board approved a 3,000-for-one stock split (the “Stock Split”) of all then-outstanding shares of Common Stock ( i.e. , the 500 shares held by Mr. Clifford and the 500 shares held by Mr. Falcigno) and authorized the execution and delivery of all documents required to effect the Stock Split.  The Board also approved an amendment to the Certificate of Incorporation to increase the total number of shares of all classes of capital stock to 25,000,000, consisting of 5,000,000 shares of Preferred Stock, and 20,000,000 shares of Common Stock.  The proposed amendment also provided the Board with “blank check” authority to divide the Preferred Stock into series, fix the designations and number of shares of those series, and determine the designations, rights and preferences of those series.  The Board adopted a resolution directing the officers of the Company to prepare a certificate of amendment, to submit the certificate of amendment to the stockholders for adoption thereby and to file the certificate of amendment with the Secretary of State.  The Company has not been able to locate a separate document reflecting the stockholders’ adoption of such amendment; however, at the time the Board executed the unanimous consent approving the amendment, all of the issued and outstanding shares of the Company’s capital stock were held by the directors.

 

The Certificate of Amendment in respect of such amendment was not filed with the Secretary of State until January 24, 2001.  Paragraph THIRD of the Certificate of Amendment recites that the amendments were adopted on January 12, 2001, by the written consent of stockholders; however, the Company has been unable to locate that consent.  In addition, the language effecting the Stock Split was omitted from the Certificate of Amendment.  On December 11, 2008, the Company filed a Certificate of Correction to the Certificate of Amendment to include language effecting the Stock Split.  Between June 7, 1999 and January 24, 2001, the Company issued shares of Common Stock in excess of the 2,000 shares of Common Stock that were authorized for issuance under the Certificate of Incorporation as in effect at the time of such issuances.  All such shares, however, were issued on the basis that the Stock Split and the amendments adopted by the Board on June 7, 1999, had then become effective, and all persons who acquired shares of Common Stock during that period acquired such shares on that basis.

 

3



 

On November 7, 2003, the Board adopted resolutions (i) acknowledging that certain corporate records were inadvertently lost and that other corporate actions were not properly documented, (ii) confirming the number of outstanding shares issued as of November 3, 2003 and (iii) ratifying the issuance of all shares of capital stock, warrants and notes of the Company as of November 3, 2003.  On November 25, 2003, the Board again ratified and approved the issuance of the Company’s then-outstanding shares, notes and warrants (as set forth on a schedule specifically identifying the name of the securityholder, the number and type of securities held by such holder, and the date on which such securities were issued to such holder) and rescinded the issuance of any shares, notes or warrants not set forth on the schedule.  The total number of outstanding shares of Common Stock as of November 24, 2003 was 5,241,548, and the total number of outstanding shares of Common Stock (assuming the conversion to Common Stock of all notes, warrants and other securities then-outstanding) was 14,125,226.  In connection with the November 25, 2003 resolutions, the Board determined that the consideration received by the Company for the issuance of such shares, notes and warrants so ratified was full and adequate.  Each holder of a security (as set forth on the schedule to the November 7, 2003 resolutions), having received notice of the facts surrounding the issues relating to the Company’s capital structure, including the record-keeping issues and other potential defects in the authorization of the issuance of the shares, executed a consent acknowledging and agreeing that the amount of securities held by such holder, as reflected on the schedule, represented such holder’s entire ownership interest in the Company’s securities.

 

On November 25, 2003, the Board approved the issuance of shares of a series of preferred stock to be designated the “Series A Convertible Preferred Stock” (the “Series A Preferred Stock”) pursuant to, and in the amount set forth in, the Securities Purchase Agreement, dated November 26, 2003, among the Company and the investors identified therein (as amended, the “Securities Purchase Agreement”), in exchange for consideration of $1 per share.  On January 30, 2004, the Board ratified the initial issuance of 1,825,000 shares of Series A Preferred Stock pursuant to the Securities Purchase Agreement, as well as the issuance of 258,333 shares of Series A Preferred Stock issued to subsequent investors pursuant to joinder agreements to the Securities Purchase Agreement.  Between February 4, 2004 and March 4, 2005, the Board authorized the issuance of an additional 2,250,000 shares of Series A Preferred Stock to Warburg Pincus Equity VIII, L.P. (“Warburg”) in exchange for consideration of $1.00 per share.  On August 30, 2004, the Board authorized the issuance of an additional 1,333,000 shares of Series A Preferred Stock to Warburg in exchange for consideration of $1.00 per share.  On December 28, 2004, the Board authorized the issuance of 3,500,000 shares of Series A Preferred Stock to Warburg in exchange for consideration of $1.00 per share.  On March 4, 2005, the Board authorized the issuance of 5,500,000 shares of Series A Preferred Stock to Warburg in exchange for consideration of $1.00 per share.  Following these issuances, the total number of shares of Series A Preferred Stock issued and outstanding was 14,666,333.

 

4



 

On November 25, 2003, the Board also approved, and the stockholders adopted, the Amended and Restated Certificate of Incorporation, which was filed with the Secretary of State and became effective on November 25, 2003 (the “First Restated Charter”).  The First Restated Charter increased the authorized number of shares of capital stock to 152,500,000, consisting of 137,000,000 shares of Common Stock and 15,500,000 shares of Preferred Stock, and provided for the creation of the Series A Preferred Stock.  Under the First Restated Charter, upon an optional conversion of the Series A Preferred Stock, the holders thereof would receive shares of Common Stock representing a value equal to the sum of (i) an amount (the “Liquidation Preference”) equal to the issue price of the Series A Preferred Stock, an 8% annual return (14% after the seventh anniversary of the date of issuance) and any declared and unpaid dividends on the Series A Preferred Stock plus (ii) an amount (the “Participation Amount”) equal to a fixed percentage of the total equity value of the Company over the Liquidation Preference (the “Common Equity Value”).  The percentage of the Common Equity Value to which the holders of the Series A Preferred Stock would be entitled is referred to herein as the “Participation Percentage.”  Under the First Restated Charter, the Participation Percentage in effect at any time was determined based on the number of shares of Series A Preferred Stock that had been issued.  The Participation Percentage was set at 20% whenever the number of shares of Series A Preferred Stock that had been issued was 750,000 or less, but the Participation Percentage increased pursuant to a formula as additional shares of Series A Preferred Stock were issued, until it reached 75% when all 15,333,333 shares of Series A Preferred contemplated by the Securities Purchase Agreement were sold.

 

Because the Participation Percentage was set at a fixed percentage, based on the number of shares of Series A Preferred Stock that had been issued, it was not subject to dilution based on the issuance of additional shares of Common Stock or other securities or the grant of management stock options.  The First Restated Charter provided, however, that if the number of stock options granted to management would have diluted the interest of the “Initial Common Stock Holders” ( i.e. , the holders of Common Stock of record as of the first date of issue of the Series A Preferred Stock) in the Common Equity Value by more than 37%, the excess dilution would proportionately dilute the Participation Percentage and the percentage interest of the Initial Common Stock Holders in the Common Equity Value.  The determination whether the 37% threshold was breached was to be made by the Board, provided that if a majority of the holders of Series A Preferred Stock or the Initial Common Stock Holders disagreed, an independent appraiser selected by such holders and the Company would make the determination.  In addition, the formula through which the conversion ratio was derived was based in part on the “Total Enterprise Value,” which required a determination of the fair market value of the Common Stock as determined by the Board.  Again, if holders of a majority of the Series A Preferred Stock or the Initial Common Stock Holders disagreed with the determination, an independent appraiser selected by such holders and the Company would make the determination.

 

The First Restated Charter provided that each share of Series A Preferred Stock would be entitled to that number of votes equal to the number of shares of Common Stock into which such share was then convertible, and further provided that, except with respect to the special voting rights of the Series A Preferred Stock set forth in the First Restated Charter and

 

5



 

except as otherwise required by law, the Series A Preferred Stock would vote together with the Common Stock as a single class on all matters.  The First Restated Charter also contained a provision specifying that, notwithstanding Section 242(b) of the General Corporation Law, the holders of Common Stock and Series A Preferred Stock shall vote together as one class on any amendment to increase the number of authorized shares of Common Stock.  This provision remained in place throughout all subsequent amendments to the Certificate of Incorporation.

 

On April 22, 2004, the Board committed that the Company would grant Bill Wenrich an option for .25% of the then-outstanding Common Stock, vested over four years and priced at the fair market value of the stock on the date of grant.  This grant was to be made in connection with Mr. Wenrich’s appointment as Independent Director.  The grant was actually made to Mr. Wenrich in February 2006 under the terms of a stockholder-ratified stock option plan.  On February 8, 2005, the Board authorized the issuance of 11,749 shares of Common Stock to Roberts Wesleyan College (“RWC”).  The Board also adopted resolutions providing that the previous resolutions authorizing the grant of an option to RWC to purchase 80,892 shares of Common Stock would be modified to authorize instead new options to purchase 59,742 shares of Common Stock, with 18,750 shares having an exercise price of $.25 and 40,992 shares having an exercise price of $.50.  On March 9, 2005, one warrant was issued to RWC with an effective date of July 1, 2004; the warrant provided an option to purchase 59,742 shares with an exercise price of $.25.  In March 2005, the Board also approved the issuance of the warrant to purchase 59,742 shares to RWC; the resolutions do not reflect the exercise price, but provide that the terms of the warrant shall be as set forth on an exhibit attached to the resolutions.  The resolutions do not include the exhibit that was to have been attached, but the Company has a copy of the warrant so issued.

 

On March 30, 2005, the Board approved the Second Amended and Restated Certificate of Incorporation (the “Second Restated Charter”), which increased the number of authorized shares to 291,200,000, consisting of 275,000,000 shares of Common Stock and 16,200,000 shares of Series A Preferred Stock, and provided that the “Participation Percentage” would be 76.11% when 16,166,133 shares had been issued.  Holders of a majority of the Series A Preferred Stock (which also constituted a majority in voting power of the outstanding stock) adopted the Second Restated Charter by written consent on March 30, 2005, and it was filed and became effective on March 30, 2005.  The Company has been unable to locate any record of a substantially contemporaneous notice of the adoption of the Second Restated Charter to the holders of capital stock entitled to vote thereon who did not execute the consent.  Such notice, however, was provided to such holders on December 23, 2008.

 

On March 30, 2005, the Board authorized the issuance of 1,500,000 shares of Series A Preferred Stock to Warburg in exchange for consideration of $1.00 per share.  Following this issuance, the total number of issued and outstanding shares of Series A Preferred Stock would have been 16,166,333.  In connection with this authorization, on July 25, 2005, the Board approved the Third Amended and Restated Certificate of Incorporation, which was filed and became effective on July 27, 2005, and on July 29, 2005, the Board approved the Fourth Amended and Restated Certificate of Incorporation, which was filed and became effective on

 

6



 

that date.  The Fourth Amended and Restated Certificate of Incorporation was filed for the sole purpose of correcting immaterial errors in the Third Restated Certificate of Incorporation; accordingly, these documents will be analyzed together for purposes of this opinion and are referred to herein as the “Fourth Restated Charter.”  Holders of a majority of the Series A Preferred Stock (which also constituted a majority in voting power of the outstanding capital stock) adopted the Fourth Restated Charter by written consent.  The Company has been unable to locate any record of a substantially contemporaneous notice of the adoption of the Fourth Restated Charter to the holders of capital stock entitled to vote thereon who did not execute the consent.  Such notice, however, was provided to such holders on December 23, 2008.

 

The Fourth Restated Charter increased the number of authorized shares to 319,850,000, consisting of 300,000,000 shares of Common Stock and 19,850,000 shares of Series A Preferred Stock, and revised the optional conversion provisions of the Series A Preferred Stock, while maintaining the principle that the holders thereof would receive a value equal to the sum of the Participation Amount and the Liquidation Preference.  The Participation Amount was to be received through the conversion of the Series A Preferred Stock into Common Stock at a fixed conversion ratio, subject to standard anti-dilution protection.  The conversion ratio was set such that if shares of Series A Preferred Stock were converted immediately, the value of the Common Stock issued would equal the Participation Amount that would have resulted from the application of the formula in the Second Restated Charter, utilizing a Participation Percentage of 85.14%.  The 9.03% increase in the Participation Percentage (over the 76.11% then in effect) was determined by dividing the $3,612,000 investment by the total equity value of the Company based on a $40 million pre-money valuation.  The fixed conversion rate structure subjected the Participation Percentage to dilution for future option grants.  Consistent with these changes, the Fourth Restated Charter also eliminated the provisions dealing with any objection by the Initial Common Stock Holders with respect to certain determinations of the Board and the appointment of an independent appraiser.

 

On July 20, 2005, the Board approved the issuance of an unsecured subordinated convertible promissory note to Warburg in a principal amount of $3,500,000, with a maturity date of September 30, 2005, at which time the holder could convert the outstanding balance into shares of Series A Preferred Stock at $1.00 per share.  The note was issued on July 27, 2005, and on that same day, Warburg sent a notice to the Company to convert the note into 3,500,000 shares of Series A Preferred Stock.  On July 26, 2005, the Board authorized the issuance of a total of 112,000 shares of Series A Preferred Stock to four members of management pursuant to a Subscription Agreement, which provided that the Company would receive consideration of $1.00 per share.  The holders of a majority of the Series A Preferred Stock approved the terms of the Subscription Agreement and the issuance.

 

On January 20, 2006, the Board approved the Company’s 2005 Stock Incentive Plan (the “Plan”), under which 29,663,925 shares of Common Stock were reserved for issuance.  This Plan was subsequently adopted by the holder of a majority of the outstanding Series A Preferred Stock (which constituted approval by a majority in voting power of the outstanding stock).  The Company has been unable to locate any record of a substantially contemporaneous

 

7



 

notice of such adoption to the holders of capital stock entitled to vote thereon who did not execute the consent.  Such notice, however, was provided on December 23, 2008.  At this meeting, the Board authorized time-vested options to the founders and to other members of senior management under the terms of the Plan, with an exercise price of $.07 per share, which the Board determined to be the fair market value of the Common Stock on the date of grant.  The Board also issued options to members of the management team outside the terms of the Plan.

 

On April 1, 2006, the Board modified Scott Turner’s employment agreement and founder options to extend the exercise period of such options.  On August 23, 2006, the Board amended the Plan to increase the number of shares of Common Stock reserved for issuance thereunder and to reserve shares of Common Stock for issuance outside the Plan.  The amendment was approved by holders of a majority of the outstanding shares of Series A Preferred Stock (which constituted a majority in voting power of the outstanding capital stock), acting by written consent, on February 12, 2007.  The Company has been unable to locate any record of a substantially contemporaneous notice of such adoption to the holders of capital stock entitled to vote thereon who did not execute the consent.  Such notice, however, was provided on December 23, 2008.

 

On February 28, 2007, the Board granted, in accordance with the terms of the Plan, time-vested options to Robert Hartman at an exercise price of $.09 per share.  On November 27, 2007, the Board approved the Amended and Restated 2005 Stock Incentive Plan (the “Amended and Restated Plan”) to increase the number of shares available for issuance thereunder and to make certain other technical changes.  At that time, the Board also eliminated the reservation of shares for issuance upon the exercise of awards outside the Amended and Restated Plan.  On that same day, the holders of a majority of the outstanding Series A Preferred Stock (which constituted a majority in voting power of the outstanding shares of capital stock) adopted the Amended and Restated Plan, acting by written consent.  The Company has been unable to locate any record of a substantially contemporaneous notice of such adoption to the holders of capital stock entitled to vote thereon who did not execute the consent.  Such notice, however, was provided on December 23, 2008.  The Board also granted, in accordance with the terms of the Amended and Restated Plan, time-vested options, with an exercise price of $.13 per share, to various individuals.

 

Issues Presented for Consideration

 

A.                                     Organizational Matters

 

The Company’s initial director was not named in the original Certificate of Incorporation.  Under the General Corporation Law, if the directors are not specifically named in the original certificate of incorporation — as in the case of the Company — the powers of the incorporator, including the power to adopt the organizational resolutions, continue until such time as the directors are elected.  In the present case, all of the organizational resolutions were adopted by Mr. Clifford, in his capacity as sole director; however, the Company has been unable to locate the consent of the incorporator appointing him as such.  Thus, there is a question as to whether Mr. Clifford, acting as sole director, had the authority to adopt the organizational

 

8



 

resolutions included in the May 21, 1999 consent of the Board, including the resolution authorizing the initial issuance of Common Stock.  We believe that the extrinsic evidence establishes that Mr. Clifford was duly elected as the sole initial director and, as such, had the authority to take the actions referenced in the initial Board consent.

 

An additional question that arises is whether the initial Board consent constituted a valid action of the Board, given that Mr. Clifford, through that consent, had expanded the size of the Board to two directors but was the only director then in office.  As a result of the expansion, the consent was adopted by unanimous written consent of the directors then in office, but by less than a majority of the total authorized directors, which raises quorum issues.  Under Section 2.6 of the Bylaws adopted by virtue of that consent, however, “[a] majority of the number of directors fixed by, or in the manner provided in, these bylaws shall constitute a quorum for the transaction of business; provided, however, that whenever, for any reason, a vacancy occurs in the board of directors, a quorum shall consist of a majority of the remaining directors until the vacancy has been filled.”  Thus, the relevant inquiry is whether the Bylaws effectively provided that a majority of the remaining directors would constitute a quorum and whether Mr. Clifford, as the sole remaining director, satisfied the minimum quorum requirements under the General Corporation Law.  In our view, Mr. Clifford, as the sole remaining director, satisfied the minimum quorum requirements under the General Corporation Law.

 

B.                                     Appointment of Louis Falcigno as a Director and Certain Subsequent Board Appointments

 

The initial Board consent provided that the “Board of Directors shall consist of two Director[s].”  The resolution establishing the size of the Board was consistent with Section 2.2 of the Bylaws as adopted by the initial Board consent.  That section provided that “the board of directors of the corporation shall consist of four (4) persons,” but further specified that “[t]he number of directors may at any time and from time to time be increased or decreased by action of either the shareholders or the board of directors.”  Thus, while the Bylaws initially called for a Board consisting of four directors, they provided that such number could be increased or decreased through an action of the Board, such as the establishment of the size of the Board adopted in the initial Board consent.  Accordingly, immediately following the adoption of the initial Board consent, there were a total of two authorized directorships: one filled by Mr. Clifford and one vacancy.

 

As indicated above, the initial Board consent did not include a resolution filling the vacancy created by the expansion of the Board.  But the immediately succeeding action of the Board included in the Company’s records—a unanimous written consent executed on June 7, 1999—reflects that each of Messrs. Clifford and Falcigno then constituted the entire Board.  In addition, Mr. Clifford’s November 20, 2003 affidavit provides that “[t]he appointment of Louis Falcigno as a director of the [Company] as of May 21, 1999, is hereby ratified.”  At this time, Mr. Clifford, as the sole director in office, had the authority under the Bylaws and the General Corporation Law to fill vacancies on the Board, and we believe that the extrinsic evidence

 

9



 

establishes that Mr. Falcigno was duly elected to the Board as of May 21, 1999 to fill the vacancy created by the expansion of the Board effected pursuant to the initial Board consent.  Subsequent to the appointment of Mr. Falcigno, additional directors were added to the Board, although there is no record in certain cases of a resolution of the Board formally expanding the size of the Board.  As indicated above, however, under the Bylaws and the General Corporation Law, the Board was authorized to increase the number of directors and to fill the vacancies created thereby.  In our view, the election by the Board of such additional directors had the effect of simultaneously expanding the size of the Board to accommodate such directors’ election to the Board.

 

C.                                     The Stock Split and Stock Issuances from the Initial Issuance through the Effectiveness of the Certificate of Amendment

 

As noted above, at its June 7, 1999 meeting, the Board approved the Stock Split and an amendment to the Certificate of Incorporation to increase the number of authorized shares of Common Stock and to authorize shares of “blank check” Preferred Stock.  The Certificate of Amendment reflecting the amendments was not filed until January 24, 2001, and the language required to effect the Stock Split was inadvertently omitted from the Certificate of Amendment.  The Certificate of Amendment was subsequently corrected to include the language effecting the Stock Split.  Following the Board’s adoption of the Stock Split and the amendments but prior to the filing of the Certificate of Amendment, the Board issued shares of Common Stock (including the shares purported to be issued pursuant to the Stock Split) in excess of the number of shares of Common Stock authorized under the Certificate of Incorporation as then in effect.  In our view, the shares issued pursuant to the Stock Split, as well as the shares issued between the time of the initial stock issuance and the effectiveness of the Certificate of Amendment, are valid, notwithstanding these defects, given that the Certificate of Correction relates back to the date of the filing of the Certificate of Amendment to cure the defects caused by the omission of the language effecting the Stock-Split (except as to parties substantially and adversely affected thereby), that the extrinsic evidence demonstrates that no relevant parties were substantially and adversely affected by the Certificate of Correction, and that the stockholders’ acknowledgment confirming the number of outstanding shares issued as of November 3, 2003 (as reflected in the Board resolutions adopted on November 7, 2003) described above constituted a valid ratification of the issuance of such other shares.

 

D.                                    Notice of Stockholder Action by Written Consent

 

As described above, on several occasions the Company amended the Certificate of Incorporation or took other actions, such as adopting the Plan and amendments thereto, with the approval of a majority in voting power (but less than all) of the stockholders entitled to vote thereon, acting by written consent.  But the Company did not provide the notice of these actions to the non-consenting stockholders, as required by the General Corporation Law and the

 

10



 

Bylaws,(1) until December 23, 2008, years after any such action was taken.  The Company’s delay in sending such notice raises questions regarding the effectiveness of such amendments and other actions.  Specifically, in cases where the amendment increased the number of authorized shares, or provided for the issuance of options up to a specified threshold, any issue regarding the effectiveness of the amendment or action could affect the validity of any shares issued under the relevant instrument.  In our view, the delay in such notice would not result in a finding that such amendments to the Certificate of Incorporation, the Plan or any amendments thereto are ineffective, nor would it result in a finding that any shares or options issued thereunder are invalid, and at most gave rise to an estoppel claim on the part of those stockholders to whom the requisite notice had not initially been provided until such time as such notice was provided.

 

E.                                       Amendment to the Second Restated Charter

 

As described above, the Company amended the Second Restated Charter to change the conversion ratio of the Series A Preferred Stock from a specified formula to a fixed ratio.  The amendments contemplated by the Fourth Restated Charter were authorized by the Series A Preferred Stock (which constituted a majority in voting power of the Company’s capital stock), acting by written consent, but no vote or consent of the holders of Common Stock, acting as a separate class, was sought or obtained.  Thus, there is a question as to whether a separate class vote of the Common Stock was required under the General Corporation Law to authorize the amendments contemplated by the Fourth Restated Charter.  In our view, no separate vote of the Common Stock was so required, because the amendment did not alter or change the powers, preferences or special rights of the Common Stock.

 

Conclusion

 

We are not aware of any case directly addressing the issues posed for our consideration.  Nonetheless, based upon and subject to our review of such matters of Delaware law as we have deemed necessary and appropriate to render our opinion as expressed herein, and subject to the assumptions, exceptions, limitations and qualifications set forth herein, it is our opinion that none of the issues presented for our consideration herein would affect the conclusions expressed in the opinion of Sheppard Mullin that if, as and when the Shares are issued and sold by the Company in accordance with the terms of the stock option or other agreements provided for under the applicable Plan or the Options or the Warrants, as applicable, and payment in full of the consideration therefor is received by the Company, the Shares will be validly issued, fully paid and nonassessable.

 


(1) At all relevant times, Section 1.4 of the Bylaws provided: “Within 10 days after obtaining authorization by written consent [pursuant to Section 228 of the General Corporation Law], notice must be given to those shareholders who have not consented in writing or who are not entitled to vote on the action.”  Section 1.4 of the Bylaws also required that the notice summarize the material features of the action so taken.

 

11



 

We are admitted to practice law in the State of Delaware and do not hold ourselves out as being experts on the law of any other jurisdiction.  The foregoing opinion is limited to the General Corporation Law currently in effect, and we have not considered and express no opinion on the effect of any other laws of the State of Delaware or the laws of any other state or jurisdiction, including state or federal laws relating to securities or other federal laws, or the rules and regulations of stock exchanges or of any other regulatory body.

 

We consent to the filing of this opinion letter as Exhibit 5.2 to the Registration Statement.  In giving this consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, the rules and regulations of the Securities and Exchange Commission promulgated thereunder or Item 509 of Regulation S-K.  We understand that Sheppard Mullin wishes to rely on this opinion in rendering its opinion to you in connection with the foregoing, and we consent to such reliance.  Except as stated above, this opinion letter is rendered to you solely for use in connection with the issuance and sale of the Shares in accordance with the Registration Statement as of the date first written above and, without our prior written consent, may not be furnished or quoted to, or relied upon by, any other person or entity for any purpose.

 

We disclaim any obligation to advise you of facts, circumstances, events or developments that hereafter may be brought to our attention and that may alter, affect or modify the opinion expressed herein.  Our opinion is expressly limited to the matters set forth above and we render no opinion, whether by implication or otherwise, as to any other matters relating to the Company or the Shares.

 

 

Very truly yours,

 

 

 

 

 

/s/ Richards, Layton & Finger P.A.

 

12


Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports dated March 19, 2009, except for Note 19, “Subsequent Events: Reverse Stock Split,” which is as of March 31, 2009 relating to the consolidated financial statements and financial statement schedule of Bridgepoint Education, Inc. and its subsidiaries, which appear in Bridgepoint Education, Inc.’s Registration Statement on Form S-1 (No. 333-156408), as amended, filed with the Securities and Exchange Commission.

 

PricewaterhouseCoopers LLP

San Diego, California

May 12, 2009

 


EXHIBIT 24.1

 

POWER OF ATTORNEY – BRIDGEPOINT EDUCATION, INC. DIRECTORS

 

KNOW ALL PERSONS BY THESE PRESENTS, that each of the undersigned directors of BRIDGEPOINT EDUCATION, INC., a Delaware corporation (the “Company”), hereby nominates and appoints ANDREW S. CLARK and DANIEL J. DEVINE, and each of them acting or signing singly, as his agents and attorneys-in-fact (the “Agents”), in his respective name and in the capacity or capacities indicated below, to execute and/or file, with all exhibits thereto, and other documents filed in connection therewith or constituting a part thereof: (1) a registration statement on Form S-8 under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the registration under the Securities Act of shares of Common Stock of the Company to be issued in connection with the Bridgepoint Education, Inc. Amended and Restated 2005 Stock Incentive Plan (the “2005 Plan”), the Bridgepoint Education, Inc. 2009 Stock Incentive Plan (as amended and restated March 31, 2009) (the “2009 Plan”), the Bridgepoint Education, Inc. Employee Stock Purchase Plan (as amended and restated March 31, 2009), certain Stock Option Agreements entered into outside of the 2005 Plan or the 2009 Plan and certain Common Stock Purchase Warrants; and (2) any one or more amendments to any part of the foregoing registration statement, including any post-effective amendments, or appendices or supplements that may be required to be filed under the Securities Act to keep such registration statement effective or to terminate its effectiveness.

 

Further, the undersigned do hereby authorize and direct such agents and attorneys-in-fact to take any and all actions and execute and file any and all documents with the Securities and Exchange Commission (the “SEC”) or state regulatory agencies, necessary, proper or convenient in their opinion to comply with the Securities Act and the rules and regulations or orders of the SEC, or state regulatory agencies, adopted or issued pursuant thereto, to the end that the registration statement of the Company shall become effective under the Securities Act and any other applicable law.

 

Finally, each of the undersigned does hereby ratify, confirm and approve each and every act and document which the said appointment agents and attorneys-in-fact may take, execute or file pursuant thereto with the same force and effect as though such action had been taken or such documents had been executed or filed by the undersigned respectively.

 

This Power of Attorney shall remain in full force and effect until revoked or superseded by written notice filed with the SEC.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Ryan Craig

 

 

 

 

Ryan Craig

 

Director

 

April 13, 2009

 

 

 

 

 

/s/ Dale Crandall

 

 

 

 

Dale Crandall

 

Director

 

April 13, 2009

 

 

 

 

 

/s/ Patrick T. Hackett

 

 

 

 

Patrick T. Hackett

 

Director

 

April 13, 2009

 

 

 

 

 

/s/ Robert Hartman

 

 

 

 

Robert Hartman

 

Director

 

April 13, 2009

 

 

 

 

 

/s/ Adarsh Sarma

 

 

 

 

Adarsh Sarma

 

Director

 

April 13, 2009

 


EXHIBIT 99.4

 

FORM OF NONSTATUTORY STOCK OPTION AGREEMENT FOR EXECUTIVES AND SENIOR MANAGEMENT FOR THE 2009 STOCK INCENTIVE PLAN

 

Grant No.             

 

BRIDGEPOINT EDUCATION, INC.

2009 STOCK INCENTIVE PLAN

NONSTATUTORY STOCK OPTION AGREEMENT

 

Bridgepoint Education, Inc., a Delaware corporation (the “Company”), hereby grants an Option to purchase shares of its Common Stock (the “Shares”) to the Optionee named below.  The terms and conditions of the Option are set forth in this cover sheet, in the attachment and in the Bridgepoint Education, Inc. 2009 Stock Incentive Plan (the “Plan”).

 

Date of Option Grant :

 

Name of Optionee :

 

Number of Shares Covered by Option :

 

Exercise Price per Share :  $

 

Fair Market Value of a Share on Date of Option Grant :  $

 

Expiration Date :

 

Vesting Calculation Date :

 

Vesting Schedule :

 

Subject to all the terms of the attached Agreement, your right to purchase Shares under this Option shall vest as to one-fourth (1/4) of the total number of Shares covered by this Option, as shown above, on the one-year anniversary of the Vesting Calculation Date.  Thereafter, the number of Shares which you may purchase under this Option shall vest as to: (i) an additional 2% of the Shares underlying this Option on each monthly anniversary of the Vesting Calculation Date over the subsequent 33-month period following such one-year anniversary of the Vesting Calculation Date, and (ii) an additional 3% of the Shares underlying this Option on each of the 46th, 47th and 48th monthly anniversaries of the Vesting Calculation Date.  If Optionee is still rendering Service upon the consummation of a Change of Control, 50% of the unvested portion of this Option shall become vested.  The remaining unvested portion of the Option shall continue to vest pursuant to its original vesting schedule but at 50% of the original rate of vesting over such vesting period.

 

[ If Optionee’s Service terminated as a result of a Qualifying Termination (as defined in Optionee’s employment agreement with the Company dated as of                                and subject to Optionee timely complying with the terms and conditions of such employment agreement) or as a result of Optionee’s death or Disability, then this Option shall become incrementally vested on an accelerated

 



 

basis on Optionee’s date of termination as if Optionee’s Service had terminated one year later.  Moreover, the outstanding unvested portion of this Option will become fully vested upon a Qualifying Termination of Optionee’s Service within the twenty-four (24) month period following a Change of Control. ]

 

[ If Optionee’s Service is terminated within the twenty-four (24) month period following a Change of Control as a result of a Qualifying Termination (as defined in Optionee’s severance agreement with the Company dated as of                                under the Executive Severance Plan and subject to Optionee timely complying with the terms and conditions of such severance agreement), then the outstanding unvested portion of this Option will become fully vested upon such Qualifying Termination of Service. ]

 

In all cases, the resulting aggregate number of vested Shares will be rounded down to the nearest whole number.  Except as may be provided above, no Shares will vest after Optionee’s Service has terminated for any reason.

 

By signing this cover sheet, you agree to all of the terms and conditions described in the attached Agreement, the Plan and Plan prospectus, copies of which are also enclosed.

 

Optionee:

 

 

 

(Signature)

 

 

 

 

Company:

 

 

 

(Signature)

 

 

 

 

Title:

 

 

 

 

 

Attachment

 

 

 



 

BRIDGEPOINT EDUCATION, INC.

2009 STOCK INCENTIVE PLAN

 

NONSTATUTORY STOCK OPTION AGREEMENT

 

The Plan and Other Agreements

 

The text of the Plan is incorporated in this Agreement by reference. Certain capitalized terms used in this Agreement are defined in the Plan.

 

This Agreement and the Plan constitute the entire understanding between you and the Company regarding this Option. Any prior agreements, commitments or negotiations concerning this Option are superseded.

 

 

 

Nonstatutory Stock Option

 

This Option is not intended to be an Incentive Stock Option under section 422 of the Code and will be interpreted accordingly.

 

This Option is not intended to be deferred compensation under section 409A of the Code and will be interpreted accordingly.

 

 

 

Vesting

 

This Option is only exercisable before it expires and then only with respect to the vested portion of the Option. This Option will vest according to the Vesting Schedule on the attached cover sheet.

 

 

 

Term

 

Your Option will expire in any event at the close of business at Company headquarters on the Expiration Date, as shown on the cover sheet. Your Option will expire earlier if your Service terminates, as described below.

 

If the Expiration Date specified in the attached cover sheet falls on a day on which the New York Stock Exchange (“NYSE”) is open for trading, then you must exercise your Option before 3:45 P.M. New York time on the Expiration Date.

 

If the Expiration Date specified in the attached cover sheet falls on any day on which the New York Stock Exchange (“NYSE”) is not open for trading, then you must exercise your Option before 3:45 P.M. New York time on the last NYSE business day immediately prior to the Expiration Date.

 

 

 

Termination - General

 

If your Service terminates for any reason (except in the case of death or Disability), other than for Cause, then your Option will expire at the close of business at Company headquarters on the date that is ninety (90) days after your termination date.

 

 

 

Termination for Cause

 

If your Service is terminated for Cause or if you commit an act(s) of Cause while this Option is outstanding, as determined by the Committee in its sole discretion, then you shall immediately forfeit all rights to your Option and the Option shall immediately expire.

 



 

Death or Disability

 

If your Service terminates because of your death or Disability, then your Option will expire at the close of business at Company headquarters on the date twelve (12) months after the date of your death or Disability. During that twelve (12) month period, your estate or heirs may exercise the vested portion of your Option.

 

 

 

Leaves of Absence

 

For purposes of this Option, your Service does not terminate when you go on a bona fide leave of absence that was approved by the Company in writing, if the terms of the leave provide for continued Service crediting, or when continued Service crediting is required by applicable law. Your Service terminates in any event when the approved leave ends unless you immediately return to active work.

 

The Company determines which leaves count for this purpose, and when your Service terminates for all purposes under the Plan.

 

 

 

Notice of Exercise

 

When you wish to exercise this Option, you must notify the Company by filing a “Notice of Exercise” form at the address given on the form. Your notice must specify how many Shares you wish to purchase. Your notice must also specify how your Shares should be registered (in your name only or in your and your spouse’s names as community property or as joint tenants with right of survivorship). The notice will be effective when it is received by the Company.

 

If someone else wants to exercise this Option after your death, that person must prove to the Company’s satisfaction that he or she is entitled to do so.

 

 

 

Form of Payment

 

When you submit your notice of exercise, you must include payment of the Exercise Price for the Shares you are purchasing. Payment may be made in one (or a combination) of the following forms:

 

 

 

 

 

·

Cash, your personal check, a cashier’s check or a money order.

 

 

 

 

 

·

Shares which have already been owned by you for more than six (6) months and which are surrendered to the Company. The Fair Market Value of the Shares, determined as of the effective date of the Option exercise, will be applied to the Exercise Price.

 

 

 

 

 

·

To the extent a public market for the Shares exists as determined by the Company, by Cashless Exercise through delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker to sell Shares and to deliver all or part of the sale proceeds to the Company in payment of the aggregate Exercise Price.

 

 

 

Withholding Taxes

 

You will be solely responsible for payment of any and all applicable taxes associated with this Option.

 

You will not be allowed to exercise this Option unless you make acceptable arrangements to pay any withholding or other taxes that may be due as a result of the Option exercise or sale of Shares acquired under this Option.

 



 

Restrictions on Exercise and Resale

 

By signing this Agreement, you agree not to (i) exercise this Option (“Exercise Prohibition”), or (ii) sell, transfer, dispose of, pledge, hypothecate, make any short sale of, or otherwise effect a similar transaction of any Shares acquired under this Option (each a “Sale Prohibition”) at a time when applicable laws, regulations or Company or underwriter trading policies prohibit the exercise or disposition of Shares. The Company shall have the right to designate one or more periods of time, each of which generally will not exceed one hundred eighty (180) days in length (provided however, that such period may be extended in connection with the Company’s release (or announcement of release) of earnings results or other material news or events), and to impose an Exercise Prohibition and/or Sale Prohibition, if the Company determines (in its sole discretion) that such limitation(s) is needed in connection with a public offering of Shares or to comply with an underwriter’s request or trading policy, or could in any way facilitate a lessening of any restriction on transfer pursuant to the Securities Act or any state securities laws with respect to any issuance of securities by the Company, facilitate the registration or qualification of any securities by the Company under the Securities Act or any state securities laws, or facilitate the perfection of any exemption from the registration or qualification requirements of the Securities Act or any applicable state securities laws for the issuance or transfer of any securities. The Company may issue stop/transfer instructions and/or appropriately legend any stock certificates issued pursuant to this Option in order to ensure compliance with the foregoing. Any such Exercise Prohibition shall not alter the vesting schedule set forth in this Agreement other than to limit the periods during which this Option shall be exercisable. Without limiting the foregoing, in connection with the Company’s April 2009 IPO, a Sale Prohibition is hereby imposed on all Shares that may be acquired under this Option with such Sale Prohibition scheduled to expire on October 12, 2009 (subject to extension as described above).

 

If the sale of Shares under the Plan is not registered under the Securities Act, but an exemption is available which requires an investment or other representation, you shall represent and agree at the time of exercise that the Shares being acquired upon exercise of this Option are being acquired for investment, and not with a view to the sale or distribution thereof, and shall make such other representations as are deemed necessary or appropriate by the Company and its counsel.

 

You may also be required, as a condition of exercise of this Option, to enter into any Company stockholder agreement or other agreements that are applicable to stockholders.

 



 

Transfer of Option

 

Prior to your death, only you may exercise this Option. You cannot transfer, assign, alienate, pledge, attach, sell, or encumber this Option. If you attempt to do any of these things, this Option will immediately become invalid. You may, however, dispose of this Option in your will or it may be transferred by the laws of descent and distribution. Regardless of any marital property settlement agreement, the Company is not obligated to honor a notice of exercise from your spouse, nor is the Company obligated to recognize your spouse’s interest in your Option in any other way.

 

 

 

Retention Rights

 

Your Option or this Agreement does not give you the right to be retained by the Company (or any Parent or any Subsidiaries or Affiliates) in any capacity. The Company (or any Parent and any Subsidiaries or Affiliates) reserves the right to terminate your Service at any time and for any reason.

 

This Option and the Shares subject to the Option are not intended to constitute or replace any pension rights or compensation and are not to be considered compensation of a continuing or recurring nature, or part of Optionee’s normal or expected compensation, and in no way represent any portion of Optionee’s salary, compensation or other remuneration for any purpose, including but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.

 

 

 

Stockholder Rights

 

You, or your estate or heirs, have no rights as a stockholder of the Company until a certificate for your Option’s Shares has been issued. No adjustments are made for dividends or other rights if the applicable record date occurs before your stock certificate is issued, except as described in the Plan.

 

 

 

Adjustments

 

In the event of a stock split, a stock dividend or a similar change in the Company stock, the number of Shares covered by this Option (rounded down to the nearest whole number) and the Exercise Price per Share may be adjusted pursuant to the Plan. Your Option shall be subject to the terms of the agreement of merger, liquidation or reorganization in the event the Company is subject to such corporate activity.

 

 

 

Legends

 

All certificates representing the Shares issued upon exercise of this Option shall, where applicable, have endorsed thereon the following legends:

 

 

 

 

 

 

“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND OPTIONS TO PURCHASE SUCH SHARES SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER, OR HIS OR HER PREDECESSOR IN INTEREST. A COPY OF SUCH AGREEMENT IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY AND WILL BE

 



 

 

 

 

FURNISHED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY BY THE HOLDER OF RECORD OF THE SHARES REPRESENTED BY THIS CERTIFICATE.”

 

 

 

 

 

 

 

“THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.”

 

 

 

Applicable Law

 

This Agreement will be interpreted and enforced under the laws of the State of Delaware.

 

 

 

Voluntary Participant

 

Optionee acknowledges that Optionee is voluntarily participating in the Plan.

 

 

 

No Rights to Future Awards

 

Optionee’s rights, if any, in respect of or in connection with this Option or any other Award are derived solely from the discretionary decision of the Company to permit Optionee to participate in the Plan and to benefit from a discretionary Award. By accepting this Option, Optionee expressly acknowledges that there is no obligation on the part of the Company to continue the Plan and/or grant any additional Awards to Optionee or benefits in lieu of Options or any other Awards even if Options have been granted repeatedly in the past. All decisions with respect to future Option grants, if any, will be at the sole discretion of the Committee.

 

 

 

Future Value

 

The future value of the underlying Shares is unknown and cannot be predicted with certainty. If the underlying Shares do not increase in value after the Date of Option Grant, the Option will have little or no value. If Optionee exercises the Option and obtains Shares, the value of the Shares acquired upon exercise may increase or decrease in value, even below the Exercise Price.

 

 

 

No Advice Regarding Grant

 

The Company has not provided any tax, legal or financial advice, nor has the Company made any recommendations regarding Optionee’s participation in the Plan, or Optionee’s acquisition or sale of the underlying Shares. Optionee is hereby advised to consult with Optionee’s own personal tax, legal and financial advisors regarding Optionee’s participation in the Plan before taking any action related to the Plan.

 

 

 

 

By signing the cover sheet of this Agreement, you agree to all of the terms and conditions described above, and in the Plan and Plan prospectus.

 


EXHIBIT 99.5

 

FORM OF INCENTIVE STOCK OPTION AGREEMENT FOR EXECUTIVES AND SENIOR MANAGEMENT FOR THE 2009 STOCK INCENTIVE PLAN

 

 

Grant No.     

 

 

BRIDGEPOINT EDUCATION, INC.

2009 STOCK INCENTIVE PLAN

INCENTIVE STOCK OPTION AGREEMENT

 

Bridgepoint Education, Inc., a Delaware corporation (the “Company”), hereby grants an Option to purchase shares of its Common Stock (the “Shares”) to the Optionee named below.  The terms and conditions of the Option are set forth in this cover sheet, in the attachment and in the Bridgepoint Education, Inc. 2009 Stock Incentive Plan (the “Plan”).

 

Date of Option Grant :

 

Name of Optionee :

 

Number of Shares Covered by Option :

 

Exercise Price per Share : $

 

Fair Market Value of a Share on Date of Option Grant : $

 

Expiration Date :

 

Vesting Calculation Date :

 

Vesting Schedule :

 

Subject to all the terms of the attached Agreement, your right to purchase Shares under this Option shall vest as to one-fourth (1/4) of the total number of Shares covered by this Option, as shown above, on the one-year anniversary of the Vesting Calculation Date.  Thereafter, the number of Shares which you may purchase under this Option shall vest as to: (i) an additional 2% of the Shares underlying this Option on each monthly anniversary of the Vesting Calculation Date over the subsequent 33-month period following such one-year anniversary of the Vesting Calculation Date, and (ii) an additional 3% of the Shares underlying this Option on each of the 46th, 47th and 48th monthly anniversaries of the Vesting Calculation Date.  If Optionee is still rendering Service upon the consummation of a Change of Control, 50% of the unvested portion of this Option shall become vested.  The remaining unvested portion of the Option shall continue to vest pursuant to its original vesting schedule but at 50% of the original rate of vesting over such vesting period.

 

[  If Optionee’s Service terminated as a result of a Qualifying Termination (as defined in Optionee’s employment agreement with the Company dated as of                                and subject to Optionee timely complying with the terms and conditions of such employment agreement) or as a result of Optionee’s death or Disability, then this Option shall become incrementally vested on an accelerated

 



 

basis on Optionee’s date of termination as if Optionee’s Service had terminated one year later.  Moreover, the outstanding unvested portion of this Option will become fully vested upon a Qualifying Termination of Optionee’s Service within the twenty-four (24) month period following a Change of Control.]

 

[ If Optionee’s Service is terminated within the twenty-four (24) month period following a Change of Control as a result of a Qualifying Termination (as defined in Optionee’s severance agreement with the Company dated as of                                under the Executive Severance Plan and subject to Optionee timely complying with the terms and conditions of such severance agreement), then the outstanding unvested portion of this Option will become fully vested upon such Qualifying Termination of Service. ]

 

In all cases, the resulting aggregate number of vested Shares will be rounded down to the nearest whole number.  Except as may be provided above, no Shares will vest after Optionee’s Service has terminated for any reason.

 

By signing this cover sheet, you agree to all of the terms and conditions described in the attached Agreement, the Plan and Plan prospectus, copies of which are also enclosed.

 

Optionee:

 

 

 

(Signature)

 

 

 

 

Company:

 

 

 

(Signature)

 

 

 

 

Title:

 

 

 

 

 

Attachment

 

 

 



 

BRIDGEPOINT EDUCATION, INC.

2009 STOCK INCENTIVE PLAN

 

INCENTIVE STOCK OPTION AGREEMENT

 

The Plan and Other Agreements

The text of the Plan is incorporated in this Agreement by reference. Certain capitalized terms used in this Agreement are defined in the Plan.

 

 

 

This Agreement and the Plan constitute the entire understanding between you and the Company regarding this Option. Any prior agreements, commitments or negotiations concerning this Option are superseded.

 

 

Incentive Stock Option

This Option is intended to be an Incentive Stock Option under section 422 of the Code and will be interpreted accordingly. If you cease to be an employee of the Company, a Subsidiary or of a Parent but continue to provide Service, this Option will be deemed a Nonstatutory Stock Option on the 90th day after you cease to be an employee. In addition, to the extent that all or part of this Option exceeds the $100,000 rule of section 422(d) of the Code, this Option or the lesser excess part will be treated as a Nonstatutory Stock Option.

 

 

 

This Option is not intended to be deferred compensation under section 409A of the Code and will be interpreted accordingly.

 

 

Vesting

This Option is only exercisable before it expires and then only with respect to the vested portion of the Option. This Option will vest according to the Vesting Schedule on the attached cover sheet.

 

 

Term

Your Option will expire in any event at the close of business at Company headquarters on the Expiration Date, as shown on the cover sheet. Your Option will expire earlier if your Service terminates, as described below.

 

 

 

If the Expiration Date specified in the attached cover sheet falls on a day on which the New York Stock Exchange (“NYSE”) is open for trading, then you must exercise your Option before 3:45 P.M. New York time on the Expiration Date.

 

 

 

If the Expiration Date specified in the attached cover sheet falls on any day on which the New York Stock Exchange (“NYSE”) is not open for trading, then you must exercise your Option before 3:45 P.M. New York time on the last NYSE business day immediately prior to the Expiration Date.

 

 

Termination - General

If your Service terminates for any reason (except in the case of death or Disability), other than for Cause, then your Option will expire at the close of business at Company headquarters on the date that is ninety (90) days after your termination date.

 



 

Termination for Cause

If your Service is terminated for Cause or if you commit an act(s) of Cause while this Option is outstanding, as determined by the Committee in its sole discretion, then you shall immediately forfeit all rights to your Option and the Option shall immediately expire.

 

 

Death or Disability

If your Service terminates because of your death or Disability, then your Option will expire at the close of business at Company headquarters on the date twelve (12) months after the date of your death or Disability. During that twelve (12) month period, your estate or heirs may exercise the vested portion of your Option.

 

 

Leaves of Absence

For purposes of this Option, your Service does not terminate when you go on a bona fide leave of absence that was approved by the Company in writing, if the terms of the leave provide for continued Service crediting, or when continued Service crediting is required by applicable law. However, no portion of this Option will be treated as an Incentive Stock Option as of the 90th day after you went on leave, unless your right to return to active work is guaranteed by law or by a contract. Your Service terminates in any event when the approved leave ends unless you immediately return to active work.

 

 

 

The Company determines which leaves count for this purpose, and when your Service terminates for all purposes under the Plan.

 

 

Notice of Exercise

When you wish to exercise this Option, you must notify the Company by filing a “Notice of Exercise” form at the address given on the form. Your notice must specify how many Shares you wish to purchase. Your notice must also specify how your Shares should be registered (in your name only or in your and your spouse’s names as community property or as joint tenants with right of survivorship). The notice will be effective when it is received by the Company.

 

 

 

If someone else wants to exercise this Option after your death, that person must prove to the Company’s satisfaction that he or she is entitled to do so.

 

 

Form of Payment

When you submit your notice of exercise, you must include payment of the Exercise Price for the Shares you are purchasing. Payment may be made in one (or a combination) of the following forms:

 

 

 

·

Cash, your personal check, a cashier’s check or a money order.

 

 

 

 

·

Shares which have already been owned by you for more than six (6) months and which are surrendered to the Company. The Fair Market Value of the Shares, determined as of the effective date of the Option exercise, will be applied to the Exercise Price.

 

 

 

 

·

To the extent a public market for the Shares exists as determined by the Company, by Cashless Exercise through delivery (on a

 



 

 

 

form prescribed by the Company) of an irrevocable direction to a securities broker to sell Shares and to deliver all or part of the sale proceeds to the Company in payment of the aggregate Exercise Price.

 

 

Withholding Taxes

You will be solely responsible for payment of any and all applicable taxes associated with this Option.

 

 

 

You will not be allowed to exercise this Option unless you make acceptable arrangements to pay any withholding or other taxes that may be due as a result of the Option exercise or sale of Shares acquired under this Option.

 

 

Restrictions on Exercise and Resale

By signing this Agreement, you agree not to (i) exercise this Option (“Exercise Prohibition”), or (ii) sell, transfer, dispose of, pledge, hypothecate, make any short sale of, or otherwise effect a similar transaction of any Shares acquired under this Option (each a “Sale Prohibition”) at a time when applicable laws, regulations or Company or underwriter trading policies prohibit the exercise or disposition of Shares. The Company shall have the right to designate one or more periods of time, each of which generally will not exceed one hundred eighty (180) days in length (provided however, that such period may be extended in connection with the Company’s release (or announcement of release) of earnings results or other material news or events), and to impose an Exercise Prohibition and/or Sale Prohibition, if the Company determines (in its sole discretion) that such limitation(s) is needed in connection with a public offering of Shares or to comply with an underwriter’s request or trading policy, or could in any way facilitate a lessening of any restriction on transfer pursuant to the Securities Act or any state securities laws with respect to any issuance of securities by the Company, facilitate the registration or qualification of any securities by the Company under the Securities Act or any state securities laws, or facilitate the perfection of any exemption from the registration or qualification requirements of the Securities Act or any applicable state securities laws for the issuance or transfer of any securities. The Company may issue stop/transfer instructions and/or appropriately legend any stock certificates issued pursuant to this Option in order to ensure compliance with the foregoing. Any such Exercise Prohibition shall not alter the vesting schedule set forth in this Agreement other than to limit the periods during which this Option shall be exercisable. Without limiting the foregoing, in connection with the Company’s April 2009 IPO, a Sale Prohibition is hereby imposed on all Shares that may be acquired under this Option with such Sale Prohibition scheduled to expire on October 12, 2009 (subject to extension as described above).

 

 

 

If the sale of Shares under the Plan is not registered under the Securities Act, but an exemption is available which requires an investment or other representation, you shall represent and agree at the time of exercise that the Shares being acquired upon exercise of

 



 

 

this Option are being acquired for investment, and not with a view to the sale or distribution thereof, and shall make such other representations as are deemed necessary or appropriate by the Company and its counsel.

 

 

 

You may also be required, as a condition of exercise of this Option, to enter into any Company stockholder agreement or other agreements that are applicable to stockholders.

 

 

 

If you sell or otherwise dispose of any of the Shares acquired pursuant to the exercise of this Option on or before the later of (i) the date that is two years after the Date of Option Grant or (ii) the date that is one year after the applicable exercise of this Option, then you shall within ten days of any and all such sales or dispositions provide the Company with written notice of such transactions including without limitation the date of each disposition, the number of Shares that you disposed of in each transaction and their original Date of Option Grant, and the amount of proceeds you received from each disposition.

 

 

Transfer of Option

Prior to your death, only you may exercise this Option. You cannot transfer, assign, alienate, pledge, attach, sell, or encumber this Option. If you attempt to do any of these things, this Option will immediately become invalid. You may, however, dispose of this Option in your will or it may be transferred by the laws of descent and distribution. Regardless of any marital property settlement agreement, the Company is not obligated to honor a notice of exercise from your spouse, nor is the Company obligated to recognize your spouse’s interest in your Option in any other way.

 

 

Retention Rights

Your Option or this Agreement does not give you the right to be retained by the Company (or any Parent or any Subsidiaries or Affiliates) in any capacity. The Company (or any Parent and any Subsidiaries or Affiliates) reserves the right to terminate your Service at any time and for any reason.

 

 

 

This Option and the Shares subject to the Option are not intended to constitute or replace any pension rights or compensation and are not to be considered compensation of a continuing or recurring nature, or part of Optionee’s normal or expected compensation, and in no way represent any portion of Optionee’s salary, compensation or other remuneration for any purpose, including but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.

 

 

Stockholder Rights

You, or your estate or heirs, have no rights as a stockholder of the Company until a certificate for your Option’s Shares has been issued. No adjustments are made for dividends or other rights if the applicable record date occurs before your stock certificate is issued, except as described in the Plan.

 



 

Adjustments

In the event of a stock split, a stock dividend or a similar change in the Company stock, the number of Shares covered by this Option (rounded down to the nearest whole number) and the Exercise Price per Share may be adjusted pursuant to the Plan. Your Option shall be subject to the terms of the agreement of merger, liquidation or reorganization in the event the Company is subject to such corporate activity.

 

 

Legends

All certificates representing the Shares issued upon exercise of this Option shall, where applicable, have endorsed thereon the following legends:

 

 

 

 

“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND OPTIONS TO PURCHASE SUCH SHARES SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER, OR HIS OR HER PREDECESSOR IN INTEREST. A COPY OF SUCH AGREEMENT IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY AND WILL BE FURNISHED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY BY THE HOLDER OF RECORD OF THE SHARES REPRESENTED BY THIS CERTIFICATE.”

 

 

 

 

 

“THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.”

 

 

 

Applicable Law

This Agreement will be interpreted and enforced under the laws of the State of Delaware.

 

 

Voluntary Participant

Optionee acknowledges that Optionee is voluntarily participating in the Plan.

 



 

No Rights to Future Awards

Optionee’s rights, if any, in respect of or in connection with this Option or any other Award are derived solely from the discretionary decision of the Company to permit Optionee to participate in the Plan and to benefit from a discretionary Award. By accepting this Option, Optionee expressly acknowledges that there is no obligation on the part of the Company to continue the Plan and/or grant any additional Awards to Optionee or benefits in lieu of Options or any other Awards even if Options have been granted repeatedly in the past. All decisions with respect to future Option grants, if any, will be at the sole discretion of the Committee.

 

 

Future Value

The future value of the underlying Shares is unknown and cannot be predicted with certainty. If the underlying Shares do not increase in value after the Date of Option Grant, the Option will have little or no value. If Optionee exercises the Option and obtains Shares, the value of the Shares acquired upon exercise may increase or decrease in value, even below the Exercise Price.

 

 

No Advice Regarding Grant

The Company has not provided any tax, legal or financial advice, nor has the Company made any recommendations regarding Optionee’s participation in the Plan, or Optionee’s acquisition or sale of the underlying Shares. Optionee is hereby advised to consult with Optionee’s own personal tax, legal and financial advisors regarding Optionee’s participation in the Plan before taking any action related to the Plan.

 

 

 

By signing the cover sheet of this Agreement, you agree to all of the terms and conditions described above, and in the Plan and Plan prospectus.

 


EXHIBIT 99.6

 

FORM OF STOCK OPTION AGREEMENT FOR OPTIONS ISSUED OUTSIDE OF PLAN

 

 

Stock Option No.    

 

BRIDGEPOINT EDUCATION, INC.
STOCK OPTION AGREEMENT

 

THIS AGREEMENT is effective as of February     , 2006 (“Date of Grant”), between Bridgepoint Education, Inc., a Delaware corporation (the “Company”), and                                   , (the “Optionee”).

 

RECITALS

 

In consideration for the Optionee’s services, the Company desires to grant to Optionee certain options to purchase shares of the Company’s common stock (“Stock”) upon the terms and conditions hereinafter set forth.

 

AGREEMENT

 

In consideration of the mutual obligations contained herein, it is hereby agreed:

 

1.                                        Grant of Options .  The Company hereby grants to the Optionee stock options to purchase from the Company Time Vested Options for                      shares of Stock, Performance Vested Options for                      shares of Stock and Exit Options for                       shares of Stock at the price of $           per share.

 

2.                                        Exercise of Option .  Subject to the other conditions set forth in this Agreement, all or part of these options may be exercised prior to their expiration at the time or times that they become vested pursuant to Vesting Schedule below; provided, however, the Optionee shall cease vesting in these options on the Optionee’s Termination Date.

 

Vesting Schedule:

 

 

 

 

 

Time Vested Options

 

Subject to Optionee’s continued Service, as defined in Section 4 herein, Optionee’s Time Vested Options shall vest as to (i) 25% of the Shares underlying such Time Vested Options on the one-year anniversary of the date of grant, (ii) as to an additional 2% of the Shares underlying such Time Vested Options on each monthly anniversary of the date of grant over the subsequent 33-month period following such one-year anniversary of the date of grant, and (iii) an additional 3% of the Shares underlying such Time Vested Options on each of the 46 th , 47 th  and 48 th  monthly anniversary of the date of grant; provided, however, in the event that Optionee’s Service is terminated by the Company without Cause or as a result of his or her death or Disability, on the date of such termination, an additional number of Time Vested Options shall vest equal to the number of Time Vested Options

 



 

 

 

that would otherwise have vested (solely as a result of the passage of time) within the 12-month period immediately following the date of such termination.

 

 

 

Performance Vested Options

 

Except as provided in Section 14.2 herein, for each fiscal year of the Company beginning with fiscal year 2005 and ending with fiscal year 2008, 25% of the Shares underlying the Performance Vested Options granted to Optionee shall be eligible to become vested and exercisable, to the extent that the Company’s actual performance for any fiscal year results in achievement of the Annual Performance Targets for such fiscal year. If in any fiscal year that either the Annual EBITDA Target or the Annual Revenue Target is not achieved (a “Missed Fiscal Year”), but in any subsequent fiscal year the Company’s cumulative EBITDA and revenue performance from and including fiscal year 2005 results in achievement of the Cumulative Performance Targets, Performance Vested Options otherwise eligible to vest during the Missed Fiscal Year(s) shall vest. All Performance Vested Options which have not vested in accordance with this paragraph shall expire as of Optionee’s termination of Service, as defined in Section 4 herein; provided, however, if Optionee’s termination of Service is as a result of his or her death or Disability, notwithstanding Section 4 herein, the Performance Vested Options eligible to vest in the fiscal year in which such termination occurs shall remain outstanding until such time that achievement of the Annual Performance Targets is determined, and to the extent achieved, such Performance Vested Options shall vest as if Optionee had remained in Service through the date of such determination, and for purposes of Section 4 herein, with respect to such Performance Vested Options only, the date of termination of Service shall be deemed to be the applicable vesting date.

 

 

 

Definitions for Performance Vested Options

 

Annual EBITDA Target ” means:

 

 

 

(a) for fiscal year 2005, ($7,430,000) or greater;

 

 

 

(b) for fiscal year 2006, ($238,000) or greater;

 

 

 

(c) for fiscal year 2007, $3,920,000; and

 

 

 

(d) for fiscal year 2008, $5,880,000;

 

 

provided, however, that the Annual EBITDA Target shall be subject to adjustment if the Company is required to secure equity funding in excess of $2.2 million following the first quarter of 2006.

 

 

 

 

 

Annual Performance Targets ” means, collectively, the Annual EBITDA Target and the Annual Revenue Target.

 

 

 

 

 

Annual Revenue Target ” means:

 

 

 

(a) for fiscal year 2005, $7,871,000;

 

 

 

(b) for fiscal year 2006, $21,808,000;

 

 

 

(c) for fiscal year 2007, $39,879,000; and

 

 

 

(d) for fiscal year 2008, $49,000,000;

 



 

 

 

provided, however, that the Annual Revenue Target shall be subject to adjustment if the Company is required to secure equity funding in excess of $2.2 million following the first quarter of 2006.

 

 

 

 

 

Cumulative EBITDA Target ” means:

 

 

 

(a) for fiscal year 2005, ($7,430,000) or greater;

 

 

 

(b) for fiscal year 2006, ($7,668,000) or greater;

 

 

 

(c) for fiscal year 2007, ($3,748,000); and

 

 

 

(d) for fiscal year 2008, $2,132,000;

 

 

provided, however, that the Cumulative EBITDA Target shall be subject to adjustment if the Company is required to secure equity funding in excess of $2.2 million following the first quarter of 2006.

 

 

 

 

 

Cumulative Performance Targets ” means, collectively, the Cumulative EBITDA Target and the Cumulative Revenue Target.

 

 

 

 

 

Cumulative Revenue Target ” means:

 

 

 

(a) for fiscal year 2005, $7,871,000;

 

 

 

(b) for fiscal year 2006, $29,679,000;

 

 

 

(c) for fiscal year 2007, $69,558,000; and

 

 

 

(d) for fiscal year 2008, $118,558,000;

 

 

provided, however, that the Cumulative Revenue Target shall be subject to adjustment if the Company is required to secure equity funding in excess of $2.2 million following the first quarter of 2006.

 

 

 

 

 

EBITDA ” means, net income plus, without duplication and to the extent deducted in determining such consolidated net income, the sum of (i) consolidated interest expense (net of any interest income), (ii) consolidated provisions for taxes based on income, profits or capital and commercial activity (or similar taxes) for such period, (iii) all amounts attributable to depreciation and amortization for such period, in each case, determined in accordance with Generally Accepted Accounting Principles.

 

 

 

 

 

Revenue ” means, the sum of all net student tuition (excluding non-cash scholarships awards), matriculation fees, room and board and other charges recognized in accordance with Generally Accepted Accounting Principles.

 

 

 

Exit Options

 

Subject to Optionee’s continued Service, as defined in Section 4 herein, through the date of an Exit Event, and provided that the Exit Factor is equal to or in excess of four, a number of Optionee’s Exit Options shall vest on such Exit Event equal to the aggregate number of Shares underlying such Exit Options multiplied by the Warburg Exit Percentage. All Exit Options which have not otherwise vested in connection with a Change of

 



 

 

 

Control due to the fact that the Exit Factor is not equal to or in excess of four (or have previously vested upon a prior Exit Event) shall expire as of the date of such Change in Control. All Exit Options which have not vested in accordance with this paragraph shall expire as of the date of Optionee’s termination of Service.

 

 

 

Definitions for Exit Options

 

“Change in Control” means: (i) a change in ownership or control of the Company effected through a transaction or series of related transactions (other than an offering of Company’s securities to the general public through a registration statement filed with the Securities and Exchange Commission) whereby any “person” or related “group” of “persons” (as such terms are used in Sections 13(d) and 14(d)(2) of the Exchange Act), other than an Affiliate of the Company or the Warburg Investors, directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of securities of the Company possessing more than fifty percent (50%) of the total combined voting power of the Company’s securities outstanding immediately after such acquisition; or (ii) the sale or conveyance of all or substantially all of the assets of the Company to a person who is not an Affiliate of the Company or the Warburg Investors.

 

 

 

 

 

Exit Event ” means a Change in Control or a Liquidity Event, as applicable.

 

 

 

 

 

Exit Factor ” means, with respect to any Exit Event, a fraction, the numerator of which is equal to the aggregate proceeds received by the Warburg Investors in connection with such Exit Event, excluding any amounts received as a result of the liquidation preference associated with such equity securities, if any, and the denominator of which is equal to the Warburg Exit Percentage multiplied by the aggregate purchase price paid by the Warburg Investors in connection with their purchase of equity in the Company.

 

 

 

 

 

Liquidity Event ” means the sale by the Warburg Investors of any portion of their equity securities of the Company to another person or group (other than any Warburg Investor or any Affiliate thereof) in which the Warburg Investors receive cash or marketable securities, and which does not otherwise constitute a Change in Control.

 

 

 

 

 

Warburg Exit Percentage ” means:

 

 

 

(a) in the case of a Liquidity Event, a percentage equal to 100 multiplied by the quotient of

 

 

 

(i) the aggregate amount of equity securities of the Company that the Warburg Investors sell in connection with such Liquidity Event (determined on a fully diluted basis), divided by

 



 

 

 

 

(ii) the aggregate amount of equity securities of the Company acquired by the Warburg Investors in connection with their purchase of equity in the Company, in each case, as adjusted for changes in capitalization; and

 

 

 

(b) in the case of a Change in Control, 100% less the sum of each Warburg Exit Percentage applicable to any Liquidity Event occurring prior to such Change in Control.

 

3.             Expiration of Option .  Subject to the provisions of Section 4 hereof, these options shall expire and all rights to purchase shares hereunder shall cease on ten (10) Years from Date of Grant (“Expiration Date”).

 

4.             Termination of Option .  In the event that the Optionee’s Service, as defined below, terminates for any reason other than due to a Disability (as defined below), death, or Cause, these options shall expire on the date that is three months following the Optionee’s termination of Service date (“Termination Date”), unless these options would expire pursuant to Section 3 at an earlier date in which case these options will expire on the earlier Expiration Date.  In the event that the Optionee’s Service terminates due to a Disability, these options shall expire on the date that is 12 months following the Optionee’s Termination Date, unless these options would expire pursuant to Section 3 at an earlier date in which case these options will expire on the earlier Expiration Date.  In the event that the Optionee should die while in Service, these options shall expire on the date that is 12 months after the Optionee’s death, unless these options would expire pursuant to Section 3 at an earlier date in which case these options will expire on the earlier Expiration Date.  In the event that the Optionee’s Service terminates for Cause, these options shall terminate on the Termination Date.  The term “Cause” shall have the meaning given to it in the Optionee’s employment or service agreement, if any, or if not so defined then the meaning given to in under California law, as interpreted by the Company.  The term “Disability” shall mean total and permanent disability as defined in Section 22(e)(3) of the Internal Revenue Code of 1986, as amended (the “Code”).  “Service” shall mean the performance of services for the Company (or any of its Affiliates) by an employee, a member of the Board, or a Consultant, as determined by the Administrator in its sole discretion.

 

5.             Non-transferability of Option .  These options shall be non-transferable by the Optionee other than by will or by the laws of descent and distribution, and shall be exercisable during the lifetime of the Optionee only by the Optionee or the Optionee’s guardian or legal representative.  After the death of the Optionee, these options may be exercised prior to its termination by the Optionee’s legal representative, heir or legatee.  Upon any attempt to sell, transfer, assign, pledge, hypothecate or otherwise dispose of these options, or of any right or privilege conferred hereby, contrary to the provisions hereof, or upon any attempted sale under any execution, attachment or similar process upon the rights and privileges conferred hereby, these options and the rights and privileges conferred hereby shall immediately become null and void.  Until written notice of any permitted passage of rights under these options shall have been given to and received by the Board of Directors of the Company (the “Board”), the Company may, for all purposes, regard the Optionee as the holder of these options.

 

6.             Method of Exercise .  The rights granted under this Agreement may be exercised by the Optionee, or by the person or persons to whom the Optionee’s rights under this Agreement shall have passed under the provisions of Section 5 hereof, by delivering to the Board, written notice of the number of shares with respect to which the rights are being exercised, accompanied by this Agreement for appropriate endorsement by the Board, the Stockholders Agreement required by Section 8 hereof, such investment letter as may be required by Section 14 hereof, and payment of the exercise price for such

 



 

shares.  No fewer than 100 shares (whole shares) may be purchased at one time, unless the number purchased is the total number at the time available for purchase under these options.  The consent of the Board must be obtained by the Optionee, and the Board shall not be obligated to give such consent, before the Optionee may exercise any of these options by delivery of consideration other than cash.

 

7.                                        Stockholders Agreement .  Notwithstanding any other provision of this Agreement to the contrary, the initial exercise of this option shall be further conditioned upon the execution and delivery by the Optionee and, if applicable, his/her spouse, of the Stockholders Agreement (in the form attached hereto as Exhibit A), to the extent not already a party thereto.  This provision shall terminate in the event of a “Qualified Public Offer,” defined as the closing of an underwritten public offering pursuant to an effective registration statement under the Act, covering the offer and sale of Stock for the account of the Company to the public generally in which the net proceeds to the Company are not less than $25 million, and in which the shares of Stock are designated for trading on the New York Stock Exchange, the Nasdaq National Market, or the American Stock Exchange.

 

7.1                                  Repurchase Rights Upon Termination of Employment .

 

7.1.1        If, prior to the date of a Qualified Public Offering, Optionee’s Service with the Company terminates for any reason, then at any time thereafter the Company shall have the right to repurchase the shares of Stock received pursuant to this Agreement at a per share price equal to the Repurchase Price, as defined below (the “Repurchase Right”).  The Repurchase Right shall be exercisable upon written notice to a Participant indicating the number of shares of Stock to be repurchased and the date on which the repurchase is to be effected, such date to be not more than thirty days after the date of such notice.  The certificates representing the shares of Stock to be repurchased shall be delivered to the Company prior to the close of business on the date specified for the repurchase.

 

7.1.2                         “Repurchase Price” shall mean, for the purpose of this Agreement:

 

(a)           on or following Optionee’s termination of Service other than by the Company for Cause, an amount equal to the Fair Market Value of the Shares on the date of repurchase; or

 

(b)           on or following Optionee’s termination of Service by the Company for Cause, the lesser of (A) the original purchase price (or Exercise Price) paid for such Shares, and (B) the Fair Market Value of the Shares on the date of repurchase.

 

7.1.3        If the Company exercises the Repurchase Right following a Participant’s termination of Service other than (A) by the Employer for Cause or (B) by a Participant’s voluntary resignation, the aggregate Repurchase Price shall be paid in a lump-sum at the time of repurchase.

 

7.1.4        If the Company exercises the Repurchase Right following a Participant’s termination of Service, (A) by the Company for Cause or (B) by such Participant, the Company shall be permitted to issue a promissory note equal to the aggregate Repurchase Price in lieu of a cash payment; provided, however, that such promissory note shall have a maturity date that does not exceed three years from the date of such repurchase, shall bear simple interest of not less than the “prime rate” in effect on the date of such repurchase, and shall be payable as to interest in equal monthly installments during the term of the note and as to principal on the maturity date.  The Company shall be permitted to assign the Repurchase Right to the Warburg Investors or any of its Affiliates that are stockholders of the Company at the time of such assignment.

 



 

8.             Regulatory Compliance .  The issuance of shares of Stock pursuant to this Agreement shall be subject to full compliance with all then applicable requirements of law and the requirements of any stock exchange or interdealer quotation system upon which the Stock may be listed or traded.

 

9.             Legends .  The certificates evidencing the Stock acquired upon exercise of an option may bear such legends as required by applicable securities laws and may refer to certain terms and conditions contained in the Optionee’s agreements with the Company.  The Company may place a stop transfer order with its transfer agent against the transfer of shares of Stock that do not bear the legends provided for above.

 

10.           Amendment or Termination .  This Agreement may be amended or terminated only by the written agreement of the Company and the Optionee.

 

11.           Tax Withholding .  As a condition to the exercise of these options, the Optionee shall make such arrangements as the Company may require for the satisfaction of any federal, state, local, or foreign tax withholding obligations that may arise in connection with such exercise.  The Optionee will pay to the Company an amount equal to the withholding amount (or the Company may withhold such amount from the Optionee’s salary) in cash.  At the Company’s election, the Optionee may pay the withholding amount with the Stock; provided, however, that payment in Stock shall be limited to the withholding amount calculated using the minimum statutory rates.

 

12.           Optionee of Shares .  Neither the Optionee nor the Optionee’s legal representative, legatee or distributee shall be, or be deemed to be, a holder of any shares of Stock subject to these options unless and until such person has been issued a certificate or certificates therefor.  No adjustment will be made for dividends or other rights for which the record date is prior to the date such stock certificate or certificates are so issued.

 

13.           Investment Covenant .  The Optionee further represents that the Optionee is acquiring these options for purposes of investment and not with a view to the distribution.  The Optionee represents and agrees that if the Optionee exercises any of these options in whole or in part at a time when there is not in effect under the Securities Act of 1933, as amended (the “Act”), a registration statement relating to the shares issuable upon exercise hereof and there is not available for delivery a prospectus meeting the requirements of Section 10(a)(3) of such Act, (i) the Optionee will acquire the shares upon such exercise for the purpose of investment and not with a view to the distribution thereof, (ii) if requested by the Company, upon each such exercise of these options, the Optionee will furnish to the Company an investment letter in form and substance satisfactory to the Company, (iii) if requested by the Company, prior to selling or offering for sale any such shares, the Optionee will furnish the Company with an opinion of counsel satisfactory to it to the effect that such sale may lawfully be made and will furnish it with such certificates as to factual matters as it may reasonably request, and (iv) certificates representing such shares may be marked with an appropriate legend describing such conditions precedent to sale or transfer.  Any person or persons entitled to exercise such option under the provision of Section 5 hereof shall furnish to the Company letters, opinions and certificates to the same effect as would otherwise be required of the Optionee.

 

14.           Changes in Capital Structure .

 

14.1                            Stock Dividends or Recapitalization .  In the event of any change in the outstanding Stock or in the capital structure of the Company by reason of a stock dividend, stock split, exchange of shares, recapitalization, subdivision or consolidation of shares, or other similar transaction effected without the receipt of consideration by the Company, the Board shall make appropriate adjustments to the purchase price of these options and to the kind and number of shares of Stock subject

 



 

to these options, to the end that the Optionee’s proportionate interest shall be maintained as before the occurrence of such event.  Any such adjustment made by the Board shall be binding upon the Optionee.

 

14.2         Merger, Consolidation, Reorganization, Liquidation, Etc .  If the Company shall become a party to any corporate reorganization, merger, liquidation, spinoff, or agreement for the sale of substantially all of its assets and property, the Board shall attempt to make appropriate arrangements, which shall be binding upon the Optionee, for the substitution of new options for any unexpired options then outstanding under this Agreement, or for the assumption of any such unexpired options, to the end that the Optionee’s proportionate interest shall be maintained as before the occurrence of such event.  If the options granted hereunder are not substituted or assumed, then (i) the Time Vested Options shall expire on the effective date of such event and the Optionee shall have 21 days prior to the expiration date to exercise these options, and the Board shall notify the Optionee of the expiration date at least 21 days prior to such date; (ii) the Exit Options shall vest to the extent provided for under the Vesting Schedule under Section 2 herein, and all Exit Options that have not otherwise vested shall expire in accordance with the Vesting Schedule; and (iii) the Performance Vested Options shall vest to the extent the applicable transaction is an Exit Event and the Exit Factor is equal to or greater than four, but otherwise shall only vest to the extent that applicable performance targets, as described in the Vesting Schedule under Section 2 herein, have been achieved, and all Performance Vested Options that have not otherwise vested shall expire on the effective date of the applicable transaction.  Notwithstanding the foregoing, the Company may cancel all outstanding options effective as of the date of the applicable transaction and deliver to Optionee in lieu thereof the difference between the Fair Market Value of a Share on the date of the applicable transaction and the Exercise Price, multiplied by the number of vested Shares that Optionee would have received had Optionee exercised the Option.  For purposes of the preceding sentence, Optionee shall be deemed to be vested in a Share if such Share is not subject to the Company’s right to repurchase at its Exercise Price.  Notwithstanding anything in this Agreement to the contrary, unless Section 280G Approval, as defined below, has been obtained, no acceleration of vesting or payment shall occur under this Section 14.2 to the extent that such acceleration or payment would, after taking into account any other payments in the nature of compensation to which the Optionee would have a right to receive from the Company and any other Person contingent upon the occurrence of such Change in Control, result in a “parachute payment” as defined in Section 280G(b)(2) of the Code.  “Section 280G Approval” shall mean the stockholder approval obtained in compliance with the requirements of Code Section 280G(b)(5)(B), as amended, and any successor thereof, and the regulations or proposed regulations promulgated thereunder, as determined by the Board in its sole discretion.

 

15.           Nondisclosure .  Optionee acknowledges that the grant and terms of these options are confidential and may not be disclosed by the Optionee to any other person, including other employees of the Company, without the express written consent of the Board.  Any breach of this provision will be deemed to be a material breach of this Agreement.

 

16.           Governing Law .  This Agreement shall be governed by and interpreted in accordance with the internal laws of the State of Delaware.

 

17.           Severability .  In the event that any one or more provisions of this Agreement shall for any reason be held invalid, illegal or unenforceable in any respect, by any court of competent jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provisions of this Agreement and the parties shall use their best efforts to substitute a valid, legal and enforceable provision which, insofar as practicable, implements the purposes and intents of this Agreement.

 

18.           Successors .  This Agreement shall inure to the benefit of and be binding upon the parties hereto and their legal representatives, heirs, and permitted successors and assigns.

 



 

19.           Rights to Future Employment .  Neither this Agreement nor the options hereunder confer upon the Optionee any right to continue in the Service of the Company, nor do they limit the right of the Company to terminate the Service of the Optionee at any time.

 

20.           Market Stand-Off .  In connection with any Qualified Public Offering, the Optionee shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer, or agree to engage in any of the foregoing transactions with respect to, any shares of stock acquired under this Agreement without the prior written consent of the Company or its underwriters.  Such restriction (the “Market Stand-Off”) shall be in effect for such period of time following the date of the final prospectus for the offering as may be requested by the Company or such underwriters.  In no event, however, shall such period exceed 180 days.  In the event of the declaration of a stock dividend, a spin-off, a stock split, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities without receipt of consideration, any new, substituted or additional securities which are by reason of such transaction distributed with respect to any shares subject to the Market Stand-Off, or into which such shares thereby become convertible, shall immediately be subject to the Market Stand-Off.  In order to enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect to the shares acquired under this Agreement until the end of the applicable stand-off period.  The Company’s underwriters shall be beneficiaries of the agreement set forth in this Section.  This Section shall not apply to shares registered in the public offering under the Act, and the Optionee shall be subject to this Section only if the directors and officers of the Company are subject to similar arrangements.

 

21.           Entire Agreement .  This Agreement constitutes the entire contract between the parties hereto with regard to the subject matter hereof.  It supersedes any other agreements, representations or understandings (whether oral or written and whether express or implied) which relate to the subject matter hereof.

 

IN WITNESS WHEREOF , the parties hereto have executed this Agreement effective as of the Date of Grant.

 

OPTIONEE

 

BRIDGEPOINT EDUCATION, INC.

 

 

 

 

 

 

By:

 

 

By:

 

Name:

 

 

Name:

Andrew S. Clark

 

 

Title:

Chief Executive Officer

Social Security Number